NCT00001651 |
|
Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients
|
View
|
NCT01663571 |
|
STAT3 in T Cells At The Crossroads of Inflammation and Cancer
|
View
|
NCT00000903 |
|
Addition of Efavirenz or Nelfinavir to a LamivudineZidovudineIndinavir HIV Treatment Regimen
|
View
|
NCT00001830 |
|
Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants
|
View
|
NCT00001650 |
|
Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients
|
View
|
NCT00001354 |
|
Interleukin-2 Therapy for HIV Infection - Supplemental Procedures
|
View
|
NCT00000882 |
|
Virologic and Immunologic Activity of Continued Lamivudine 3TC vs Delavirdine DLV in Combination With Indinavir IDV and Zidovudine ZDV or Stavudine d4T in 3TC-Experienced Subjects
|
View
|
NCT00000859 |
|
A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral AR Nucleoside Therapy in HIV-Infected Individuals With CD4 Cell Counts Less Than or Equal to 200mm3
|
View
|
NCT00001316 |
|
Viral Load in Blood and Lymph Tissues of HIV-Infected Individuals
|
View
|
NCT00001967 |
|
Intermittent Versus Continuous Medication in the Treatment of HIV
|
View
|
NCT00000675 |
|
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin rCd4-IgG Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex
|
View
|
NCT00001540 |
|
The Use of Bacteriophage Phi X174 to Assess the Immune Competence of HIV-Infected Patients In Vivo
|
View
|
NCT00000886 |
|
A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate IFA
|
View
|
NCT00001350 |
|
Study of Autoimmune Lymphoproliferative Syndrome ALPS
|
View
|
NCT00001096 |
|
A Phase I Multicenter Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX BE HIV-1 MN rgp120A244 rgp120 in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults
|
View
|
NCT00001409 |
|
Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications
|
View
|
NCT00000672 |
|
An Efficacy Study of 23-Dideoxyinosine ddI BMY-40900 Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
|
View
|
NCT00001644 |
|
Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection
|
View
|
NCT00013533 |
|
Pilot Study of Non-Myeloablative HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies
|
View
|
NCT00013884 |
|
HIV Maintenance Therapy With T-20 During HAART Interruption
|
View
|
NCT00025909 |
|
Intermittent vs Continuous HAART to Treat Chronic HIV Infection
|
View
|
NCT00025922 |
|
Influenza Vaccine in HIV Infection Immune Response and Effect on Viral Load
|
View
|
NCT00001038 |
|
A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients
|
View
|
NCT00031343 |
|
The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin
|
View
|
NCT00050856 |
|
Fuzeon Enfuvirtide Early Access Program for Patients With HIV-1 Infection
|
View
|
NCT00069914 |
|
Immune Response to Influenza Vaccine in HIV-Infected Individuals
|
View
|
NCT00071890 |
|
Phase IIIII Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cellsmm3 Who Received Antiretroviral Tx
|
View
|
NCT00079911 |
|
A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons
|
View
|
NCT00101374 |
|
Effect of Leflunomide on T Cell Proliferation in HIV-Infected Patients
|
View
|
NCT00105417 |
|
Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment
|
View
|
NCT00120185 |
|
Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients ANRS119
|
View
|
NCT00150891 |
|
Th1 Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
|
View
|
NCT00167674 |
|
ARVs to Prevent Breastmilk HIVViral and Immune Responses
|
View
|
NCT00160849 |
|
Lopinavirr Monotherapy as Maintenance Therapy After Long Term Viral Suppression
|
View
|
NCT00197522 |
|
Administration of Autologous Dendritic Cells DCs Infected With an Adenovirus Expressing Her-2
|
View
|
NCT00261001 |
|
Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route
|
View
|
NCT00247845 |
|
Evaluation of Atazanavir Substitution Intervention EASI Study
|
View
|
NCT00001082 |
|
The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients
|
View
|
NCT00001353 |
|
Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs
|
View
|
NCT00257907 |
|
Immune Response to Mycobacterium Tuberculosis Infection
|
View
|
NCT00080431 |
|
Daclizumab to Treat HIV-Infected Patients
|
View
|
NCT00270465 |
|
Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients
|
View
|
NCT00286767 |
|
Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy
|
View
|
NCT00314093 |
|
RFT-5-dgA in Patients With Metastatic Melanoma
|
View
|
NCT03846206 |
|
Mediterranean Diet and Bacterial Translocation and Immune-activation in Patients With HIV
|
View
|
NCT00342355 |
|
Antiretroviral Therapy for Advanced HIV Disease in South Africa
|
View
|
NCT00340990 |
|
Immune Responses to Mycobacterium Tuberculosis
|
View
|
NCT00340548 |
|
Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort HGDS-3
|
View
|
NCT00386633 |
|
Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara MVA Virus to Treat HIV Infection
|
View
|
NCT00385450 |
|
Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor
|
View
|
NCT00390078 |
|
Single-Blind Controlled Safety and Immunogenicity Study of Recombinant MVA Virus to Treat HIV Infection
|
View
|
NCT01760356 |
|
Study of PDPKPG Relationships of Tacrolimus and Cyclosporin in Liver Transplant Patients
|
View
|
NCT00001443 |
|
A Phase I II Study of the Protease Inhibitor Indinavir MK-0639 in Children With HIV Infection
|
View
|
NCT00433056 |
|
Long Term Treatment Interruptions
|
View
|
NCT00433979 |
|
Study of Pharmacokinetics in HIV-infected Women
|
View
|
NCT00477321 |
|
Safety Study of IL-7 in HIV-infected Patients Inspire
|
View
|
NCT00480350 |
|
RiSolubles the Soluble Fraction of Rice Bran for HIV-Infected Patients
|
View
|
NCT00521287 |
|
Impaired Immunity in Patients With Cancer Influence of Cancer Stage Chemotherapy and Cytomegalovirus Infection
|
View
|
NCT00535236 |
|
A Study of an Investigational V212Heat-Treated Varicella-Zoster Virus VZV Vaccine in Immunocompromised Adults V212-002
|
View
|
NCT00557570 |
|
Evaluation and Monitoring of Patients With HIV Infectionn
|
View
|
NCT00559416 |
|
Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy
|
View
|
NCT01852877 |
|
Seek Test Treat Retain An Integrated Jail-Prison-Community Model for Illinois
|
View
|
NCT00584051 |
|
Examination of the Role of Atrial Natriuretic Peptide Polymorphisms in Allergic Rhinitis and Asthma Severity
|
View
|
NCT00583167 |
|
CNS Central Nervous System Viral Dynamics and Cellular Immunity During AIDS
|
View
|
NCT00614458 |
|
MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4 T Cell HIV Infection
|
View
|
NCT01900106 |
|
A Prospective Open-label Trial of Two ABC3TC Based Regimens in Late Presenter naïve Patients CD4 200 CellsµL
|
View
|
NCT00654316 |
|
Study of the Safety and Immunogenicity of Bacille Calmette Guerin BCG Vaccine
|
View
|
NCT00709007 |
|
Directly Administered Antiretroviral Therapy DAART Among HIV-1infected Injecting Drug Users IDUs in Chennai India
|
View
|
NCT01694420 |
|
Treatment of Acute HIV Infection With Quad Fixed-dose Combination FDC Tablet
|
View
|
NCT00703404 |
|
Response to Standard HIV Treatment in Bamako Mali
|
View
|
NCT00752856 |
|
Raltegravir LopinavirRitonavir Versus Efavirenz Tenofovir Emtricitabine in Treatment Naive Patients
|
View
|
NCT00757900 |
|
Efficacy of Influenza Vaccine in HIV Infected Adults
|
View
|
NCT00722644 |
|
Cognitive Behavioral Stress Management for HIV Drug Abusers
|
View
|
NCT00761371 |
|
Imiquimod 5 Cream in the Treatment of External Genital or Perianal Warts in HIV Patients
|
View
|
NCT00819806 |
|
CpG 7909Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors
|
View
|
NCT04661254 |
|
Treg Cell Therapy in Liver and Kidney Transplantation - Preclinical Validation of Batches of Treg Cells Amplified in Vitro
|
View
|
NCT00839436 |
|
Interleukin-7 CYT107 Treatment of Idiopathic CD4 Lymphocytopenia Expansion of CD4 T Cells ICICLE
|
View
|
NCT00847106 |
|
Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients
|
View
|
NCT00842634 |
|
Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV
|
View
|
NCT00863668 |
|
Raltegravir Activity In Lymphoid Tissues
|
View
|
NCT02090101 |
|
Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer
|
View
|
NCT00877656 |
|
HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma
|
View
|
NCT00875368 |
|
Maraviroc Immune Recovery Study
|
View
|
NCT00959361 |
|
Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy
|
View
|
NCT01898195 |
|
Improving Adherence to Smoking Cessation Medication Among PLWHA
|
View
|
NCT01161199 |
|
The Use of Leukapheresis to Support HIV Pathogenesis Studies
|
View
|
NCT01168167 |
|
Impact of Raltegravir on HIV-1 cDNA Slope Following Antiretroviral Therapy ART Initiation
|
View
|
NCT01160445 |
|
Phase II Study of Aldesleukin IL-2 Following the Administration of Zanolimumab Anti-CD4mAb in Metastatic Melanoma and Metastatic Renal Cancer
|
View
|
NCT00974285 |
|
Clinical Trials on the Effect of Immunity 1 Fuzheng 1 on Immune Reconstitution of HIV Patients
|
View
|
NCT01192035 |
|
PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial
|
View
|
NCT01225289 |
|
Impact of Vitamin A Supplementation on Immune System in Multiple Sclerosis Patients
|
View
|
NCT01252537 |
|
Immunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia
|
View
|
NCT00979420 |
|
Non-interventional Observational Study With Viramune Nevirapine and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx 10 Years With Viramune
|
View
|
NCT04325438 |
|
The Impact of Pharmacists Interventions on the Quality of Life of HIV-TB Co-infection Outpatients in Indonesia
|
View
|
NCT01322581 |
|
A Longitudinal Systems Biological Analysis of Naturally Acquired Malaria Immunity in Mali
|
View
|
NCT01346800 |
|
Pharmacokinetic Interaction Between Ritonavir and Prasugrel in Healthy Volunteers
|
View
|
NCT01340222 |
|
Monocyte Chemotactic Protein-1 MCP-1 Expressing Monocytes to Predict Preterm Delivery PhenoMAP Study
|
View
|
NCT03444064 |
|
PolyTreg Immunotherapy in Islet Transplantation
|
View
|
NCT01378494 |
|
Bone Mineral Density in HIV Patients
|
View
|
NCT01381757 |
|
Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali
|
View
|
NCT01405352 |
|
The Effect of Vitamin A Supplementation on Cytokine Profile in Obesity
|
View
|
NCT01417988 |
|
Prevention of Early Mortality by Presumptive Tuberculosis TB Treatment
|
View
|
NCT01456962 |
|
Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract
|
View
|
NCT01492985 |
|
Lipopeptide Immunisation With GTU-multiHIV Trial
|
View
|
NCT01515813 |
|
Effect of HAART Vs Statin Treatment on Endothelial Function and InflammationCoagulation
|
View
|
NCT01513135 |
|
A Phase Il of a Therapeutic Recombinant Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected Anti-Tat Negative ARV-Treated Adult Volunteers
|
View
|
NCT01519141 |
|
Inflammation Viral Replication and Atherosclerosis in Treated HIV Infection
|
View
|
NCT01557998 |
|
Testing and Linkage to Care for Injecting Drug Users in Kenya
|
View
|
NCT03618862 |
|
Study of the Effects of Farnesoid X Receptor FXR Ligands on the Reactivation of Latent Provirus
|
View
|
NCT01600989 |
|
Mitochondrial Function of Immune Cells in Sepsis
|
View
|
NCT01710397 |
|
Rapid Initiation of Antiretroviral Therapy to Promote Early HIVAIDS Treatment in South Africa RapIT Study
|
View
|
NCT00339456 |
|
Intermittent Versus Continuous HAART Highly Active Antiretroviral Therapy for Treating Chronic HIV Infected Patients in Uganda
|
View
|
NCT01805752 |
|
Optimizing Integrated PMTCT Services in Rural North-Central Nigeria
|
View
|
NCT00993031 |
|
Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
|
View
|
NCT01859832 |
|
Validation of a Novel Diagnostic Tool for the Evaluation of Post Renal Transplant Immunosuppression The ImmuKnow Assay
|
View
|
NCT01858909 |
|
Efficacy of Melatonin in Patients With Severe Sepsis or Septic Shock
|
View
|
NCT01861054 |
|
Pilot Study to Evaluate Safety Biological Effects of Orally Administered Reparixin in Early Breast Cancer
|
View
|
NCT01876862 |
|
Towards HIV Functional Cure
|
View
|
NCT01893112 |
|
Reducing HIV Stigma for African American Women
|
View
|
NCT01908049 |
|
Treatment With Probiotics Saccharomyces Boulardii and Its Role in Bacterial Translocation and Immune Reconstitution in VIH Infection
|
View
|
NCT01904201 |
|
Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People
|
View
|
NCT03605953 |
|
Expansion of Invariant NKT Cells for a Cell Immunotherapeutic Approach Allowing the Control of Graft Versus Host-disease and Preserving the Graft Versus Leukemia Effect After Allogeneic Hematopoietic Stem Cell Transplantation
|
View
|
NCT01977885 |
|
Exercise-Induced Epigenetic Modifications in Obese Aging Women
|
View
|
NCT02015013 |
|
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
|
View
|
NCT02038387 |
|
Prospective Clinical Study of the Role of the Immune Response in Relation to Diet in Patients Affected by Either Chronic Hepatitis C Virus HCV Infection or Non Alcoholic Fatty Liver Disease NAFLD
|
View
|
NCT02054286 |
|
Safety Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy HAART
|
View
|
NCT02052492 |
|
Safety Study of EF-022 Modified Vitamin D Binding Protein Macrophage Activator in Subjects With Advanced Solid Tumors
|
View
|
NCT02063880 |
|
Pediatric Urgent Start of Highly Active Antiretroviral Treatment HAART
|
View
|
NCT02081638 |
|
Elite Controller and ART-treated HIV Statin Versus ASA Treatment Intervention Study
|
View
|
NCT02118454 |
|
Antiretroviral Adherence and Quality-of-life Support for HIV Patients in India With Twice-daily Interactive Voice Response IVR Calls With Health and Mental Health Messaging Compared to Weekly IVR Survey Only Control Condition The Mobile-messaging Adherence and Support for Health Study India
|
View
|
NCT00013611 |
|
Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients With Low CD4 Counts SILCAAT Study
|
View
|
NCT00992433 |
|
H1N1 Vaccine at Two Dose Levels in HIV Positive Adults
|
View
|
NCT02147405 |
|
PET Imaging and Lymph Node Assessment of IRIS in People With AIDS
|
View
|
NCT02261688 |
|
Salt and TH-17 in Healthy Human Subjects
|
View
|
NCT02274415 |
|
Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells Disease
|
View
|
NCT02291081 |
|
A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected Patients
|
View
|
NCT02361541 |
|
Determination of HCV Prevalence in a HIV Patient Cohort in Phnom Penh Cambodia
|
View
|
NCT00006494 |
|
Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs
|
View
|
NCT01293513 |
|
Structured Treatment Interruption STI in AcutePrimary HIV
|
View
|
NCT02434848 |
|
A Pilot Study Comparing the Immunogenicity of Fendrix vs Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses
|
View
|
NCT02441231 |
|
Probiotic Visbiome for Inflammation and Translocation in HIV II
|
View
|
NCT02840474 |
|
Phase 1 Open-label Single Dose Study to Examine Safety Tolerability Pharmacokinetics and Virologic Impact of VRC01LS or VRC07-523LS in HIV-infected Viremic Adults
|
View
|
NCT02448238 |
|
Pilot Study of Oral Probiotic Bacteria Supplementation to Reduce Chronic Immune Activation in HIV-infected Malian Women
|
View
|
NCT04651439 |
|
Severe Bullous Drug Eruption and Filgrastim
|
View
|
NCT02473328 |
|
Study Evaluating the Efficacy of a Reduced Dose Atazanavir in HIV-1-infected Patients
|
View
|
NCT02526940 |
|
Impact of Pre-ART Blood CD4 T Cell Level on the Rectal Reservoir in Long-term HIV-1 Treated Men
|
View
|
NCT01570439 |
|
To Identify HLA-A1101-restricted Peptide Epitopes Derived From Novel Oncoantigens URLC10 KIF20A and CDCA1 Applicable for Cancer Vaccine in Singapore
|
View
|
NCT02539472 |
|
Early Diagnosis of Mycosis Fungoides
|
View
|
NCT02557061 |
|
Prognostic Value of the Lymphocytic Infiltrate in Colon Cancers
|
View
|
NCT02596334 |
|
Study to Evaluate the Efficacy of MONotherapy of TiviCAY Versus a Triple Therapy in HIV-1-infected Patients
|
View
|
NCT00867269 |
|
Etiology Pathogenesis and Natural History of Idiopathic CD4 Lymphocytopenia
|
View
|
NCT02659306 |
|
Metformin Immunotherapy in HIV Infection
|
View
|
NCT00367731 |
|
NOW Thai HAART Study
|
View
|
NCT02712866 |
|
Early Biomarkers in Circulating α 4β7 T Cells to Predict Response to Vedolizumab in Inflamatory Bowel Disease Patients
|
View
|
NCT02712671 |
|
Testing for Tuberculosis in the United Kingdom HIV Infected Population
|
View
|
NCT00009009 |
|
Kidney Transplant for HIV-Infected Patients in Renal Failure
|
View
|
NCT00000822 |
|
A Phase III Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500mm3 CD4 T Cells and 200-400mm3 CD4 T Cells
|
View
|
NCT02741362 |
|
Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis Systemic Lupus Erythematosus or Sharps Syndrome
|
View
|
NCT02765776 |
|
An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens in Aged HIV Patients RalAge
|
View
|
NCT02788175 |
|
Vedolizumab Anti-alpha4beta7 in Subjects With HIV Infection Undergoing Analytical Treatment Interruption
|
View
|
NCT02793219 |
|
Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer
|
View
|
NCT05910138 |
|
Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia Areata
|
View
|
NCT00562874 |
|
Nutrition Intervention in Drug Naive HIV-infected Kenyan Women and Their Children
|
View
|
NCT02908360 |
|
Study of the Frequency and of the Regulatory Function of Positive T Lymphocytes Dual CD4CD8aa DP8a Specific to a Bacteria of the Intestinal Microbiota Faecalibacterium Prausnitzii in Atopic Dermatitis Asthma and Allergic Rhinitis
|
View
|
NCT02923076 |
|
HIV Eradication Through Cord-blood Transplantation
|
View
|
NCT03008941 |
|
Microbiota Restoration Therapy in HIV With Repeated Low-Dose Interventions
|
View
|
NCT03066128 |
|
Point-of-care Viral Load Testing to Enable Streamlined Care and Task Shifting for Chronic HIV Care
|
View
|
NCT03087890 |
|
Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria
|
View
|
NCT03091374 |
|
Impact of Recombinant Human Growth Hormone on HIV Persistence
|
View
|
NCT02891135 |
|
Simplified Algorithm for Treatment Eligibility
|
View
|
NCT03117985 |
|
Tracking and Exploring the Source of Viral REbound
|
View
|
NCT03124914 |
|
Relationship Between Neuromuscular Fatigue Perceived Tiredness and Level Of Physical Activity of Patients Living With HIV
|
View
|
NCT03140657 |
|
The Effects of Nanocurcumin on Treg Cells and Th17 Cells Responses in Ankylosing Spondylitis Patients
|
View
|
NCT03155113 |
|
Role of the Host Immunity in the Non-response to Direct Anti-viral Agent DAA Therapy
|
View
|
NCT03168945 |
|
Xpert Active Case-finding Trial 2 Community-based Active Case-finding for Tuberculosis in South Africa
|
View
|
NCT03198325 |
|
Monitored Antiretroviral Pause in Chronic HIV-Infected Subjects With Long-Lasting Suppressed Viremia
|
View
|
NCT04208711 |
|
Role of PLA2G1B During HIV Infection
|
View
|
NCT03280940 |
|
Impact of Different Integrase Inhibitor Based Regimen on Immune Activation Among HIV naïve Patient INTATTI
|
View
|
NCT00301561 |
|
Antiretroviral Treatment Simplified Follow-up Management Assessment ANRS 12110 STRATALL
|
View
|
NCT03366922 |
|
Evaluation of Artemisia Annua and Moringa
|
View
|
NCT03410680 |
|
A Habit-formation and Gamification Intervention to Improve ART Adherence Among MSM HIV Patients in Mexico
|
View
|
NCT00001941 |
|
Anti-Tac for Treatment of Leukemia
|
View
|
NCT04620304 |
|
Study for Evaluation of the Safety Pharmacokinetics and Antiviral Activity of UB-421 Subcutaneous Formulation Administered in HIV-1 Infected Treatment Naive Patients
|
View
|
NCT00002063 |
|
Treatment of AIDS and AIDS Related Complex Part-1- Treatment of Patients With ARC AZT Vs Placebo
|
View
|
NCT03618381 |
|
EGFR806 CAR T Cell Immunotherapy for RecurrentRefractory Solid Tumors in Children and Young Adults
|
View
|
NCT03666871 |
|
CCR5-modified CD4 T Cells for HIV Infection
|
View
|
NCT05243381 |
|
Inflammation NK Cells Antisense Protein and Exosomes and Correlation With Immune Response During HIV Infection
|
View
|
NCT03672682 |
|
SMOLY Phenotype and Functions of Monocyte Subtypes in High Grade B Lymphoma Towards New Biomarkers
|
View
|
NCT03795649 |
|
The Immunomodulatory Effect of Antrifibrinolytic Tranexamic Acid in Total Knee Arthroplasty
|
View
|
NCT03886038 |
|
Subunit Vaccine Against Herpes Zoster in RA Patients Treated With JAK-inhibitors VACCIMIL-ZOSTER
|
View
|
NCT03920969 |
|
Sport and Self Esteem in Patients Living With HIV
|
View
|
NCT02569736 |
|
Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation
|
View
|
NCT00001703 |
|
Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma
|
View
|
NCT03985137 |
|
Role of the Balano-preputial Furrow s Microbiota in Circumcised Patients or Not in the Acquisition or Transmission of HIV
|
View
|
NCT04002323 |
|
Real Life Study of Dolutegravir Plus Lamivudine in HIV-1-Infected Treatment-Naive Patients
|
View
|
NCT04054544 |
|
Gluten Challenge Study in Celiac Disease Participants MK-0000-402
|
View
|
NCT04062825 |
|
Interaction Between HIV and Platelets
|
View
|
NCT04097561 |
|
Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies Phoebe
|
View
|
NCT04156048 |
|
HIVHEART Aging Study 125 Year Follow up
|
View
|
NCT04180059 |
|
Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation
|
View
|
NCT00162682 |
|
Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand
|
View
|
NCT04229290 |
|
Second-line Switch to Dolutegravir Study
|
View
|
NCT04246983 |
|
Point-of Care Ultrasound for Patients With HIV
|
View
|
NCT04263051 |
|
Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung Cancer
|
View
|
NCT04297501 |
|
Gut Microbiota Changes of HIV Patients Before and After One Year of ART
|
View
|
NCT04330287 |
|
HIV-HEART Aging Study
|
View
|
NCT04343963 |
|
Pyridostigmine in Severe SARS-CoV-2 Infection
|
View
|
NCT04354207 |
|
Vitamin D and Its Receptor Gene Polymorphisms in Lithuanian Latvian and Taiwanese Patients With Atopic Dermatitis and Asthma
|
View
|
NCT04353180 |
|
Assessment the Activity Value of Isotretinoin 13- Cis-Retinoic Acid in the Treatment of COVID-19 Isotretinoin in Treatment of COVID-19 Randomized
|
View
|
NCT04369495 |
|
BAFF Levels and Lupus Nephritis LN
|
View
|
NCT04362995 |
|
St Jude Tracking of Viral and Host Factors Associated With COVID-19
|
View
|
NCT04411043 |
|
Observatory of Prolymphocytic Leukemia T
|
View
|
NCT00226434 |
|
Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis ANRS 1295 CAMELIA
|
View
|
NCT04483778 |
|
B7H3 CAR T Cell Immunotherapy for RecurrentRefractory Solid Tumors in Children and Young Adults
|
View
|
NCT04513626 |
|
HIV-1 Infected Patients Phase II Trial Dual Combination DoravirineRaltegravir Open Label
|
View
|
NCT05144698 |
|
RAPA-201 Therapy of Solid Tumors
|
View
|
NCT00287495 |
|
BAY 43-9006 Sorafenib to Treat Patients With Kaposis Sarcoma
|
View
|
NCT04641806 |
|
Clinical and Immunological Evolution of Covid-19 Occurring in a Context of Non-Hodgkin Lymphoma
|
View
|
NCT04653194 |
|
Efficacy of BICFTAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of Test and Treat
|
View
|
NCT04666311 |
|
Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis
|
View
|
NCT06050330 |
|
CD4 T Cells and S100A7 Epression in Normal and Psoriatic Skin A Histological and Histochemical Study
|
View
|
NCT04802382 |
|
Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
|
View
|
NCT04836780 |
|
DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia
|
View
|
NCT01926379 |
|
ENhance Initiation and Retention in Isoniazid Preventive Therapy IPT Care for HIV Study ENRICH Study
|
View
|
NCT04902443 |
|
Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
|
View
|
NCT04938518 |
|
Latent HIV-1 Viral Suppress and Hope for HIV Cure
|
View
|
NCT05000294 |
|
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
|
View
|
NCT05044676 |
|
Immune Cells as a New Biomarker of Response in Patients Treated by Immunotherapy for Advanced Hepatocellular Carcinoma
|
View
|
NCT05050461 |
|
Immune Response After SARS-CoV-2 Vaccination in a Context of Non-Hodgkin Lymphoma
|
View
|
NCT01926184 |
|
RCT of an Integrative Intervention for Non-Treatment-Seeking Meth Users
|
View
|
NCT05215704 |
|
Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV
|
View
|
NCT05332808 |
|
Treatment State and Quality of Life in HIV- Infected Patients in Upper Egypt
|
View
|
NCT00002250 |
|
A Phase I Study of Recombinant Human CD4 Immunoglobulin G rCD4-lgG in Patients With HIV-Associated Immune Thrombocytopenic Purpura
|
View
|
NCT00199979 |
|
Zidovudine Lamivudine Nevirapine Twice Daily Versus Tenofovir Lamivudine Nevirapine Once Daily in ARV-Naive Patients
|
View
|
NCT05422313 |
|
Assessment of Galectin-9 in Rheumatoid Arthritis and Its Correlation With Disease Activity
|
View
|
NCT02332486 |
|
Based on Metabonomics Dryness Pathogen Type of OLP a Dynamic Study
|
View
|
NCT02691065 |
|
Protease Inhibitor vs Raltegravir-based ART and Inflammation in HIV Infection
|
View
|
NCT00076804 |
|
Helping HIV Infected Patients in South Africa Adhere to Drug Regimens
|
View
|
NCT05544448 |
|
In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune Allo-immune or Inflammatory Diseases
|
View
|
NCT05568953 |
|
An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity
|
View
|
NCT01089400 |
|
Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage
|
View
|
NCT02113930 |
|
Idiopathic CD4 Lymphocytopenia
|
View
|
NCT05600920 |
|
A Single-arm Dose-escalation Trial of Long-acting Recombinant Human IL-7 NT-I7 Efineptakin Alfa for Idiopathic CD4 Lymphopenia
|
View
|
NCT01082692 |
|
Study of PENNVAX-B Gag Pol Env Electroporation in HIV-1 Infected Adult Participants
|
View
|
NCT05633927 |
|
Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed
|
View
|
NCT00000650 |
|
An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate DTC in HIV-Infected Patients
|
View
|
NCT02126683 |
|
The Effect of Plaquenil on Serum Inflammatory Markers and Goiter in Euthyroid Young Women With Hashimotos Thyroiditis
|
View
|
NCT02465580 |
|
A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus
|
View
|
NCT05746845 |
|
Implication of 5-HT7 Receptor in Inflammatory Mechanisms in Multiple Sclerosis
|
View
|
NCT05827562 |
|
Alterations in CD8αβ and CD8αα T Cell Levels in Patients With Rheumatoid Arthritis
|
View
|
NCT00002267 |
|
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex MAC Bacteremia in AIDS Patients With CD4 Counts or 200 A Double-Blind Placebo-Controlled Trial
|
View
|
NCT02611895 |
|
Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy
|
View
|
NCT05930951 |
|
Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck
|
View
|
NCT05685641 |
|
Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City
|
View
|
NCT00001080 |
|
Effect of Vaccination on Turnover of Lamivudine 3TC Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals
|
View
|
NCT06039527 |
|
TINO T Cells in the Nose of Older Adults
|
View
|
NCT00006209 |
|
A Study of Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs
|
View
|
NCT02509364 |
|
Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis AE-IPF
|
View
|
NCT05526118 |
|
Advanced HIV Outcomes for Rapid ART
|
View
|
NCT01102192 |
|
The Role of the Thymus in Myasthenia Gravis
|
View
|
NCT06363500 |
|
Characterization of HIV-1 Reservoirs in HIV-1 Non-B Infected Adolescents on ART in Cameroon
|
View
|
NCT01103076 |
|
Effects of High Cut-off HCO Hemodialysis on Central Memory CD4 T and Treg Cells in Patients With End-stage Kidney Disease
|
View
|
NCT06217094 |
|
Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma HCC Undergoing Y-90 Treatment
|
View
|
NCT05860335 |
|
Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer
|
View
|
NCT05772728 |
|
Chidamide Combined With Azacitidine and Mitoxantrone Liposome in the Treatment of RelapsedRefractory nTFHL
|
View
|
NCT06272500 |
|
Exploring Methods for Treating Hypergastrinemia in Patients With Autoimmune Gastritis
|
View
|
NCT02416531 |
|
Vulvar Lichen Sclerosus Comparison Between Clobetasol Propionate Photodynamic Therapy and Low-Intensity Laser
|
View
|
NCT06327581 |
|
Combined Microneedling With Either 1 Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata
|
View
|
NCT01117077 |
|
The Immune Tolerance Mechanism Induced by IL-17-producing Regulatory T Cells in the Orthotopic Liver Transplant Recipients With Aspergillosis
|
View
|
NCT06375642 |
|
A Single Arm Single Centered Phase II Trial on the Combination of Adebrelimab Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC
|
View
|
NCT00089700 |
|
TNX-355 With Optimized Background Therapy OBT in Treatment-Experienced Subjects With HIV-1
|
View
|
NCT03067155 |
|
CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation
|
View
|
NCT03213223 |
|
Retention of Women in the PMTCT Prevention of Mother-to-child Transmission of HIV
|
View
|
NCT03823365 |
|
Blinatumomab Expanded T-cells BET in Indolent Non-Hodgkin LymphomasChronic Lymphocytic Leukemia
|
View
|
NCT04185038 |
|
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine GliomaDiffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
|
View
|
NCT04541290 |
|
Tacrolimus as Treatment of Breast Cancer-Related Lymphedema
|
View
|
NCT01125228 |
|
Effectiveness of Zidovudine vs Zidovudine Plus Alpha Interferon vs Interferon for Treatment of HIV
|
View
|
NCT05475028 |
|
Network Medicine Approaches to Classify Heart Failure With PReserved Ejection Fraction by Signatures of DNA Methylation and Point-of-carE Risk calculaTors PRESMET
|
View
|
NCT02953080 |
|
Improving Outcomes in HIV Patients Using Mobile Phone Based Interactive Software Support
|
View
|
NCT03367754 |
|
A Single Dose of Pembrolizumab in HIV-Infected People
|
View
|
NCT03453801 |
|
The Role of CD4 Memory Phenotype Memory and Effector T Cells in Vaccination and Infection
|
View
|
NCT03468582 |
|
123I Radiolabeled 3BNC117
|
View
|
NCT03500991 |
|
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive RecurrentRefractory Pediatric CNS Tumors
|
View
|
NCT01123655 |
|
Phase 1 Trial of Type II Collagen CII APL A12 in Rheumatoid Arthritis Patients
|
View
|
NCT04894448 |
|
Immunogenicity of COVID-19 Vaccination in PLWH
|
View
|
NCT04990557 |
|
CRISPRCas9-modified Human T Cell PD-1and ACE2 Knockout Engineered T Cells for Inducing Long-term Immunity in COVID-19 Patients
|
View
|
NCT00002343 |
|
A Study of Rifabutin Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex MAC Bacteremia in Patients With AIDS
|
View
|
NCT00005120 |
|
The Safety and Effectiveness of -Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
|
View
|
NCT00002407 |
|
A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs
|
View
|
NCT00002172 |
|
An Expanded Access Open-Label Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 CellsMl
|
View
|
NCT01141205 |
|
HIV-1 Peptide Immunisation of Individuals in West Africa to Prevent Disease
|
View
|
NCT01140126 |
|
Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults
|
View
|
NCT00428116 |
|
Optimizing Pediatric HIV-1 Treatment Nairobi Kenya
|
View
|
NCT00002043 |
|
Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia PCP in Patients With AIDS-Related Complex ARC
|
View
|
NCT00002106 |
|
A Pilot Randomized Double-Blind Placebo-Controlled Parallel Design Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cellsmm3
|
View
|
NCT00001993 |
|
Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine AZT to Symptomatic HIV-1 Infected Patients With or 200 to or 500 CD4 Cellsmm3
|
View
|
NCT00002185 |
|
A Pilot Open-Label Phase II Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 500 Cellsmm3
|
View
|
NCT02401828 |
|
The Dolutegravir Antiretroviral Mono-Therapy for HIV Trial
|
View
|
NCT04320797 |
|
Urinary T Cell Biomarker for Prediction in Lupus Nephritis
|
View
|
NCT01155037 |
|
Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults
|
View
|
NCT00344487 |
|
Pilot Study of Effect of Kaletra on CD4 Response in HIV Positive Patients With Viral Suppression KIMBO Study
|
View
|
NCT00006066 |
|
Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems
|
View
|
NCT01680094 |
|
Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
|
View
|
NCT00000872 |
|
Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection
|
View
|
NCT00162643 |
|
PI Vs NNRTI Based Therapy for HIV Advanced Disease
|
View
|
NCT00031070 |
|
Increasing HAART-Induced Immune Restoration With Cyclosporine
|
View
|
NCT00045357 |
|
Biological Therapy in Treating Patients With Metastatic Melanoma
|
View
|
NCT00242216 |
|
The Once A Day Protease Inhibitor Regimens
|
View
|
NCT00057421 |
|
Tuberculosis in HIV Infected Patients in Uganda
|
View
|
NCT00059462 |
|
Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection
|
View
|
NCT01191281 |
|
Improving Food Security and Nutrition to Promote ART Adherence in Latin America
|
View
|
NCT01190111 |
|
Study on Interleukin-7 CYT107 in HIV Patients
|
View
|
NCT00002123 |
|
A Double-Blind Randomized Comparative Study of Delavirdine Mesylate U-90152S in Combination With Didanosine ddI Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of 300mm3
|
View
|
NCT00006441 |
|
Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV
|
View
|
NCT01200979 |
|
Assessment of Alterations in Immune Function During Pregnancy and Post Parturition
|
View
|
NCT00241930 |
|
Integrating Buprenorphine Into HIV Treatment
|
View
|
NCT00002000 |
|
A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride 256U87 Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients
|
View
|
NCT00002438 |
|
A Study of Itraconazole in the Prevention of Histoplasmosis a Fungal Infection in HIV-Infected Patients
|
View
|
NCT01225406 |
|
Third Line Highly Active Antiretroviral Therapy HAART in HIV-infected Children
|
View
|
NCT01650389 |
|
Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination
|
View
|
NCT00004978 |
|
An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy
|
View
|
NCT00002436 |
|
The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT
|
View
|
NCT00001319 |
|
Evaluation of HIV-Negative Patients With Low CD4 T Lymphocyte Counts
|
View
|
NCT00001899 |
|
Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy
|
View
|
NCT00071240 |
|
Growth Hormone to Increase Immune Function in People With HIV
|
View
|
NCT01171495 |
|
Impact of Nutrition Intervention on HIVAIDS Infected Patients
|
View
|
NCT00002311 |
|
The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients
|
View
|
NCT00001068 |
|
A Study of Disease Progression and Anti-HIV Treatments
|
View
|
NCT00002100 |
|
Phase III Study of Curdlan Sulfate
|
View
|
NCT01241643 |
|
Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders
|
View
|
NCT04368468 |
|
Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC
|
View
|
NCT01240525 |
|
Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers
|
View
|
NCT00071071 |
|
Clinical Trial of HuMax-CD4 a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin
|
View
|
NCT00038259 |
|
Interleukin-2 IL-2 Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy
|
View
|
NCT04371809 |
|
DNA Methylation Analysis in Acute Coronary Syndrome and Atrial Fibrillation DIANA Clinical Trial
|
View
|
NCT00002124 |
|
A Double-Blind Randomized Dose Response Study of Three Doses of Delavirdine Mesylate U-90152S in Combination With Zidovudine ZDV Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3
|
View
|
NCT00034216 |
|
Collection of Blood From Patients With Cancer
|
View
|
NCT01289106 |
|
Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects
|
View
|
NCT00101257 |
|
Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
|
View
|
NCT00194519 |
|
Herpes Simplex Virus Type 2 HSV-2 Suppression to Prevent HIV Transmission
|
View
|
NCT00113282 |
|
Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure ANRS123
|
View
|
NCT01296529 |
|
Study on Immunopathogenesis in HIV and Hepatitis C Coinfection
|
View
|
NCT00119106 |
|
Bangkok Tenofovir Study an HIV Pre-exposure Prophylaxis Trial Bangkok Thailand
|
View
|
NCT00376935 |
|
Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults
|
View
|
NCT00402142 |
|
Dendritic Cell Vaccine in HIV-1 Infection
|
View
|
NCT00122551 |
|
Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy HAART
|
View
|
NCT00491556 |
|
Preservation and Expansion of T-cell Subsets Following HAART De-intensification to AtazanavirRitonavir ATVr
|
View
|
NCT00495651 |
|
Early Antiretroviral Treatment andor Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults ANRS 12136 TEMPRANO
|
View
|
NCT01306188 |
|
Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients
|
View
|
NCT02817178 |
|
Study for Validation of Immunological Biomarkers in Patients With Metastatic Colorectal Cancer
|
View
|
NCT02818426 |
|
Universal Cancer Peptide-based Vaccination in Metastatic NSCLC
|
View
|
NCT01300988 |
|
Effects of Treatment With Aprepitant Emend in HIV Infected Individuals 375 mg Dose
|
View
|
NCT00000709 |
|
An Open Trial of Zidovudine AZT Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4 Lymphocyte Counts
|
View
|
NCT01666990 |
|
Tripterygium Wilfordii Hook F TwHF Treatment for Immune Non-responders With HIV-1 Infection
|
View
|
NCT00507221 |
|
Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression
|
View
|
NCT00017771 |
|
Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs
|
View
|
NCT00011037 |
|
ALVAC-HIV vCP1452 Alone and Combined With MN rgp120
|
View
|
NCT00158470 |
|
Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam ANRS 1210 VIETAR
|
View
|
NCT00168207 |
|
IL-7 Receptor Polymorphisms and Immune Recovery With HAART
|
View
|
NCT00518154 |
|
Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response
|
View
|
NCT00946556 |
|
Examining the Ability of Herpes Simplex Virus Type 2 HSV2 Therapy to Reduce HIV Target Cell Numbers in the Cervix
|
View
|
NCT01500096 |
|
American Ginseng to Improve HIV-Associated Fatigue A Randomized Placebo-Controlled Parallel Design Multiple-Dose Clinical Trial
|
View
|
NCT00189930 |
|
An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs MVA-BN in HIV-1 Infected Patients
|
View
|
NCT00196599 |
|
Pilot Study on Once Daily FTC ddI Efavirenz Combination in Antiretroviral Naive HIV Infected Adults
|
View
|
NCT00445029 |
|
Pathophysiological Study of Allergic Contact Dermatitis to Para-Phenylenediamine PPD Analysis of Cellular and Molecular Targets in Skin Inflammation
|
View
|
NCT04397861 |
|
T Cell Memory Fuels the Innate Response in Chronic CF Lung Disease
|
View
|
NCT02741128 |
|
Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults
|
View
|
NCT00536120 |
|
The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis
|
View
|
NCT04397809 |
|
Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic Fibrosis
|
View
|
NCT00329251 |
|
Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV
|
View
|
NCT00338390 |
|
Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDITDF With ABC3TC
|
View
|
NCT01370018 |
|
Therapy to Elevate CD4 Counts in HIV-1 Disease
|
View
|
NCT00353327 |
|
Study of the Effectiveness of Passive Immunotherapy in HIV-Infected Patients Who Are in Virologic Failure
|
View
|
NCT00356616 |
|
Immuno-Virological Efficacy of Combination With Trizivir Tenofovir in Multiresistant HIV Patients
|
View
|
NCT00496340 |
|
Phase II Trial of Pentostatin and Targeted Busulfan
|
View
|
NCT00385957 |
|
Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100
|
View
|
NCT00386659 |
|
Immune Reconstitution in naïve HIV Patients With CD4 100 CellsmL When Treated With Lopinavir or Efavirenz
|
View
|
NCT00531557 |
|
Double Protease Inhibitor to Darunavir Switch Study
|
View
|
NCT00405925 |
|
FREE Study Efficacy and Toxicity of Trizivir
|
View
|
NCT00407836 |
|
Efficacy Study of T Cell Vaccination in HIV Infection
|
View
|
NCT00428519 |
|
Effects of Treatment With Aprepitant Emend in HIV Infected Individuals
|
View
|
NCT00434512 |
|
Dose-ranging Study to Evaluate the Safety Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers
|
View
|
NCT01150747 |
|
Chlamydia Trachomatis Immunology and Vaccinology Study
|
View
|
NCT01904994 |
|
Link4Health A Combination Strategy for Linkage and Retention Swaziland
|
View
|
NCT00461266 |
|
ESP Study A Study to Assess the Effect of Adding Fuzeon Enfuvirtide to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression
|
View
|
NCT01912521 |
|
Mfangano Island Healthy Networks Impact Study
|
View
|
NCT04453436 |
|
HIV Drug Resistance Among Individuals Failing TenofovirLamivudine and Dolutegravir First Line Regimen in Brazil
|
View
|
NCT01473810 |
|
Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant
|
View
|
NCT00517569 |
|
Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
|
View
|
NCT01921101 |
|
Intensive Nutrition in Acute Respiratory Distress Syndrome ARDS A Clinical Trial INTACT
|
View
|
NCT00520897 |
|
Integrase Inhibitor MK-0518 Viral Decay
|
View
|
NCT00532168 |
|
Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4 Cell Counts Below 100 CellsMcl
|
View
|
NCT02848105 |
|
Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHD
|
View
|
NCT01042301 |
|
Profiling of Original Cellular and Humoral Biomarkers of Type 1 Diabetes
|
View
|
NCT04498325 |
|
Evaluating the Effect of NT-I7 a Long Acting Interleukin-7 to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 COVID-19
|
View
|
NCT00581802 |
|
HIV Resistance and Treatment Strategies
|
View
|
NCT00944541 |
|
Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration
|
View
|
NCT00602784 |
|
Phase II Study of Immunization With a Hepatitis C Virus HCV Antigen Peptide Vaccine
|
View
|
NCT00610597 |
|
Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease
|
View
|
NCT04503928 |
|
Euphorbia Kansui and HIVAIDS Functional Cure
|
View
|
NCT01942655 |
|
IL-23IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection
|
View
|
NCT00623259 |
|
Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected Subjects
|
View
|
NCT00627380 |
|
Yoga for the Management of HIV-Metabolic Syndromes
|
View
|
NCT00631449 |
|
Raltegravir Intensification in HIV-infected Patients
|
View
|
NCT01571466 |
|
A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART
|
View
|
NCT01840046 |
|
Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata
|
View
|
NCT01052649 |
|
Gene Expression Monitoring of Mononuclear Cells MNC Subpopulations and Immunological Status and Metabolome Defining of Healthy Population
|
View
|
NCT00705926 |
|
Effectiveness of Antiretroviral Therapy During Acute HIV Infection
|
View
|
NCT00706550 |
|
Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects
|
View
|
NCT00709111 |
|
Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression
|
View
|
NCT00713531 |
|
Cohort Study of HIV-1 Incidence Among Clients of the Thai Red Cross AIDS Research Center Bangkok Thailand
|
View
|
NCT04547738 |
|
Influence of Filarial Infections on Tuberculosis Disease and Tuberculosis Vaccination in Cameroon
|
View
|
NCT04546698 |
|
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
View
|
NCT00757250 |
|
Safety Study of TXA127 to Elevate CD4 T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy
|
View
|
NCT04553081 |
|
2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial
|
View
|
NCT01608269 |
|
Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy
|
View
|
NCT00000838 |
|
Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine Stavudine or Didanosine
|
View
|
NCT00773708 |
|
Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product
|
View
|
NCT00792324 |
|
Pilot Study Switching Individuals Receiving EFV With Continuing Central Nervous System Toxicity to TMC125
|
View
|
NCT01612169 |
|
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
|
View
|
NCT02302352 |
|
Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic Sclerosis
|
View
|
NCT02191293 |
|
Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune
|
View
|
NCT02191319 |
|
Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor NRTI Regimens
|
View
|
NCT02191332 |
|
Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune-Containing Therapy Regimen
|
View
|
NCT01627678 |
|
Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART
|
View
|
NCT02191527 |
|
Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services in Mozambique
|
View
|
NCT00911664 |
|
Vitamin D Supplementation and CD4 Count in HIV-Infected Children
|
View
|
NCT00848211 |
|
Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects
|
View
|
NCT00851786 |
|
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
|
View
|
NCT01632891 |
|
Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected
|
View
|
NCT03426592 |
|
Effect of High Dose Vitamin D Supplementation on HIV Latency
|
View
|
NCT00867048 |
|
Strategic Timing of Antiretroviral Treatment
|
View
|
NCT01635153 |
|
Effects of a Protein Calorie Supplement in HIV-infected Women With Tuberculosis
|
View
|
NCT00000663 |
|
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G rCD4-IgG in Infants and Children With Documented HIV-1 Infection
|
View
|
NCT01642888 |
|
A Trial in Subjects Suspected to Have Tuberculosis Comparing the Diagnostic Performance of C-Tb to QuantiFERON in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI
|
View
|
NCT00893516 |
|
CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma
|
View
|
NCT00895206 |
|
Individually Adapted Immunosuppression in de Novo Renal Transplantation Based on Immune Function Monitoring a Prospective Randomised Study
|
View
|
NCT01650558 |
|
Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on ART in Malawi
|
View
|
NCT01299948 |
|
Progression of HIV-Disease Under Low Dose Corticosteroids
|
View
|
NCT00925756 |
|
CCR5 Inhibitor Treatment Intensification on CD4 T-cell Recovery
|
View
|
NCT04629274 |
|
In Vitro Study of the Biological and Immunological Activity of Imotopes Candidates on Blood Cells of Patients With Stabilized NMO
|
View
|
NCT00205231 |
|
A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor TNF Inhibition on HIV Disease
|
View
|
NCT00951795 |
|
Accuracy of the Pima CD4 Test for Enumeration of CD4 T-Cell Counts
|
View
|
NCT00963222 |
|
The Study of the Effects of Vitamin A on Immune System in Patients With Atherosclerosis
|
View
|
NCT02840058 |
|
Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 PDL1
|
View
|
NCT02316691 |
|
B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease
|
View
|
NCT01679067 |
|
Gut Associated Lymphatic Tissue GALT in HIV Human Immunodeficiency Virus- Infected Patients
|
View
|
NCT00688311 |
|
Pilot Trial of a Synbiotic in HIV Patients
|
View
|
NCT01016223 |
|
A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic Esophagitis
|
View
|
NCT01017536 |
|
Safety and Immunogenicity of AERAS-402 in HIV-infected Bacillus Calmette-Guerin BCG-Vaccinated Adults
|
View
|
NCT02240381 |
|
Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant
|
View
|
NCT01048372 |
|
Observational Study of Blood Treated With Cytolin
|
View
|
NCT01053325 |
|
Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy
|
View
|
NCT01697540 |
|
Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan
|
View
|
NCT00002091 |
|
An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score 40 Percent and 100 Percent
|
View
|
NCT01704781 |
|
Vacc-4x Lenalidomide vs Vacc-4x Placebo in HIV-1-infected Subjects on Antiretroviral Therapy ART
|
View
|
NCT01077310 |
|
Alcohol Pharmacotherapy for HIV Prisoners
|
View
|
NCT01701882 |
|
A Pilot Study to Assess the Feasibility of Switching Individuals Receiving Atripla With Continuing Central Nervous System CNS Toxicity to a Fixed Dose Combination of TenofovirEmtricitabineRilpivirine
|
View
|
NCT01091792 |
|
Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme GBM
|
View
|
NCT00002087 |
|
Safety Tolerance Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals
|
View
|
NCT02603536 |
|
WelTelOAKTREE Text Messaging to Support Patients With HIVAIDS in British Columbia
|
View
|
NCT01712256 |
|
Re-boosting of HIV-1 Infected Subjects With Vacc-4x
|
View
|
NCT01713400 |
|
Tacrolimus Sirolimus and Ustekinumab vs Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
|
View
|
NCT01134939 |
|
Non-interventional Observational Study With Viramune in HIV to Evaluate Gender Specific Data
|
View
|
NCT01722552 |
|
China Adherence Through Technology Study
|
View
|
NCT01165203 |
|
Study to Evaluate GSK Biologicals Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus HIV-Infected Subjects
|
View
|
NCT01167491 |
|
Study of One Protein Implicated in Wegener Disease
|
View
|
NCT02146027 |
|
Once a Day Use of Lactobacillus Casei Shirota on HIV-infected Patients Infected Patients
|
View
|
NCT04741100 |
|
Evaluation of Innovative Combinatorial stratégies of Anti-latency and Anti-immune Activation Drugs Targeting HIV Reservoir
|
View
|
NCT04756687 |
|
Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera
|
View
|
NCT01731691 |
|
Safety and Efficacy of α1Proteinase Inhibitor α1PI in HIV Disease
|
View
|
NCT01734850 |
|
Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection
|
View
|
NCT01044654 |
|
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
|
View
|
NCT02337322 |
|
Immune Recovery in Advanced ARV-naïve HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir
|
View
|
NCT01213810 |
|
Prevention of Varicella Zoster Virus VZV-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine PROVE-IT-Study
|
View
|
NCT01232712 |
|
A Study to Assess the Safety and Efficacy of MUC1 Peptide Vaccine and hGM-CSF in Patients With MUC1-positive Tumor Malignancies
|
View
|
NCT01746199 |
|
Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum
|
View
|
NCT01246401 |
|
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive HIV Criminal Justice Populations
|
View
|
NCT01245101 |
|
Addition of Raltegravir to Established Antiretroviral Suppressive Therapy
|
View
|
NCT04770701 |
|
Protect and Improve Cluster of Differentiation 4 CD4 Cells and B Cells Lymphocytes
|
View
|
NCT00000771 |
|
A Double-Blind Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cellsmm3
|
View
|
NCT00001025 |
|
Evaluation of Patients Who Have Not Had Success With Zidovudine
|
View
|
NCT01741311 |
|
Secondary HIV Prevention and Adherence Among HIV-infected Drug Users
|
View
|
NCT02334670 |
|
Vietnam Cryptococcal Retention in Care Study Version 10
|
View
|
NCT02300623 |
|
Intermittent ART in Primary HIV Infection
|
View
|
NCT00480792 |
|
Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients
|
View
|
NCT01750879 |
|
Tolerance Following Peanut Oral Immunotherapy
|
View
|
NCT01758367 |
|
Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic LeukemiaAML After Allogeneic Stem Cell Transplantation
|
View
|
NCT01758783 |
|
Therapy of Radiation Enteritis With Glutamine
|
View
|
NCT01768182 |
|
Folinic Acid and Vascular Reactivity in HIV
|
View
|
NCT01319383 |
|
The Effect of Vorinostat on HIV RNA Expression in the Resting CD4 T Cells of HIV Pts on Stable ART
|
View
|
NCT02434172 |
|
CryptoART Study Decreasing Mortality Associated With Initiation of Antiretroviral Therapy in Sub-Saharan Africa
|
View
|
NCT01325636 |
|
Injection of CD4 and CD8 T Cells Anti-Cytomegalovirus CMV or Anti-adenovirus
|
View
|
NCT01327755 |
|
Rwanda Selenium Supplementation Clinical Trial
|
View
|
NCT02718456 |
|
Overcoming Barriers to HIVAIDS Care and ART Initiation
|
View
|
NCT01339403 |
|
Kaiser Permanente HIV Cohort Study
|
View
|
NCT01338883 |
|
Efficacy Safety and Tolerability of Cenicriviroc CVC in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected Antiretroviral Treatment-naïve Adult Patients Infected With Only CCR5-tropic Virus
|
View
|
NCT02441244 |
|
Probiotic Visbiome for Inflammation and Translocation in HIV Ι
|
View
|
NCT01777997 |
|
FTCRPVTDF on T-Cell Activation CD4 T-Cell Count Inflammatory Biomarkers and Viral Reservoir
|
View
|
NCT01770730 |
|
A Trial of the Urine LAM Strip Test for TB Diagnosis Amongst Hospitalized HIV-infected Patients
|
View
|
NCT01365065 |
|
Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy
|
View
|
NCT01368107 |
|
Study Evaluating Impact of IL-7 on CD4 Lymphopenia Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients
|
View
|
NCT02390297 |
|
Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients
|
View
|
NCT02500446 |
|
Dolutegravir Impact on Residual Replication
|
View
|
NCT01787994 |
|
Redirected MazF-CD4 Autologous T Cells for HIV Gene Therapy
|
View
|
NCT01414972 |
|
The Effect of Vitamin A on Atherosclerosis
|
View
|
NCT01433289 |
|
Study to Evaluate Safety and Toxicity of Polyphenon E EGCG in HIV-1-Infected Individuals
|
View
|
NCT01797367 |
|
Pulmonary Substudy A Substudy of Strategic Timing of AntiRetroviral Treatment START
|
View
|
NCT01471821 |
|
Study to Evaluate the Activity and Tolerability of LopinavirRitonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression
|
View
|
NCT01479634 |
|
Early HIV Therapy in Patients With High CD4 Cell Counts
|
View
|
NCT01509508 |
|
Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence
|
View
|
NCT00000761 |
|
Phase III Study of Recombinant Human Interferon-gamma rIFN-gamma in HIV-Infected Children
|
View
|
NCT05134597 |
|
Gene Expression in Chronic Venous Leg Ulcers
|
View
|
NCT01791556 |
|
Clinic-based ART Diagnostic Evaluation
|
View
|
NCT01799161 |
|
Combination of gp96-Ig Vaccine Theophylline and Oxygen for the Treatment of Patients With Advanced Relapsed or Metastatic Non-Small Cell Lung Cancer
|
View
|
NCT01583439 |
|
The Mochudi Prevention Project ART Protocol
|
View
|
NCT04943978 |
|
Prospective Studies on Immunopathogenesis of Liver Fibrosis
|
View
|
NCT02427776 |
|
A Trial for Evaluating Both Safety and Preliminary Efficacy of a Single Infusion of Stimulated Autologous CD4T Cells in Patients With Relapsing- Remitting Multiple Sclerosis
|
View
|
NCT01668043 |
|
Study to Evaluate Safety and Efficacy of UB-421 Antibody in HIV-1 Infected Adults
|
View
|
NCT03110094 |
|
Investigation of Immunological and Pharmacological Factors for Response to Adalimumab in Rheumatoid Arthritis
|
View
|
NCT03068949 |
|
Comparison of Three Licensed Influenza Vaccines
|
View
|
NCT00002359 |
|
A Multicenter Double-Blind Phase III Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen Remune Compared to Incomplete Freunds Adjuvant IFA Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 CellsmicroL Rega
|
View
|
NCT01728922 |
|
Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome
|
View
|
NCT05089370 |
|
Oral DecitabineCedazuridine DEC-C in Combination with Nivolumab for Patients with Mucosal Melanoma
|
View
|
NCT03202758 |
|
Evaluation of the Safety and the Tolerability of Durvalumab Plus Tremelimumab Combined With FOLFOX in mCRC
|
View
|
NCT01764581 |
|
Randomized Controlled Trial of ImmuKnow in Liver Transplantation
|
View
|
NCT01776151 |
|
Arterial Elasticity A Substudy of Strategic Timing of AntiRetroviral Treatment START
|
View
|
NCT00493506 |
|
ProAlgaZyme Novel Algae Infusion Applications in Immunodeficiency
|
View
|
NCT01817283 |
|
Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders
|
View
|
NCT03145922 |
|
Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis
|
View
|
NCT01013415 |
|
CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 IL-2 In HIV Patients
|
View
|
NCT01852942 |
|
Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
|
View
|
NCT01866540 |
|
Immune Response To Intranasal Influenza Vaccination
|
View
|
NCT01869634 |
|
Mechanisms of Immune Reconstitution Reduced Immune Activation Following Darunavir-based ART
|
View
|
NCT01904877 |
|
Multi-component HIV Intervention Packages for Chinese Men Who Have Sex With Men -Test Link and Care TLC
|
View
|
NCT05219916 |
|
Selection of Farnesoid X Receptor FXR Ligands on the Reactivation of Latent HIV Proviruses
|
View
|
NCT05222009 |
|
G-CSF in Patients With Anti-PD-1-axis Therapy-resistant Recurrent or Metastatic Nasopharyngeal Carcinoma
|
View
|
NCT01944371 |
|
Short-term Disulfiram Administration to Reverse Latent HIV Infection a Dose Escalation Study
|
View
|
NCT03200054 |
|
Postpartum Adherence Clubs for Antiretroviral Therapy
|
View
|
NCT05261191 |
|
A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy
|
View
|
NCT02028819 |
|
Compassionate Use of Ibalizumab for the Treatment of HIV Infection
|
View
|
NCT01802736 |
|
Alcohol Use and Risky Sexual Behaviors Among HIV Infected Subjects in Kampala Uganda
|
View
|
NCT02038582 |
|
Strategies to Increase HIV Testing Linkages to Care and Male Circumcision in Africa
|
View
|
NCT04068441 |
|
Measurement for Viral Reservoir and Immune Function in HIV-1-infected Patients Under Antiretroviral Therapy
|
View
|
NCT02049437 |
|
AIDS 347 IL-6 Blockade in Treated HIV Infection
|
View
|
NCT05328765 |
|
A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection
|
View
|
NCT03238755 |
|
Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins A Cardiac MRI Study
|
View
|
NCT05350865 |
|
Thailand HDV Cohort
|
View
|
NCT03241784 |
|
T-Regulatory Cells in Amyotrophic Lateral Sclerosis
|
View
|
NCT05362916 |
|
Letermovir in ART-treated HIV-infected Persons
|
View
|
NCT02119130 |
|
Quantiferon Gold Test for Detecting Tuberculosis TB Infection in HIVAIDS Patients in South Africa
|
View
|
NCT03397576 |
|
Adherence Through Home Education and Nursing Assessment Indonesia
|
View
|
NCT03403569 |
|
Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection
|
View
|
NCT02176135 |
|
Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV Infection
|
View
|
NCT05419024 |
|
Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
|
View
|
NCT01810289 |
|
The START a Streamlined ART Initiation Strategy Study
|
View
|
NCT03280290 |
|
Transplant T CD4 CCR7 In Hematopoietic Stem Cells Allograft
|
View
|
NCT02236234 |
|
Immune Response to HPV Vaccine Among HIV-1-infected Subjects in Brazil
|
View
|
NCT03421314 |
|
Effect of Zinc and Selenium Supplementation on HIV Individuals on Antiretroviral Treatment
|
View
|
NCT02263326 |
|
Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure
|
View
|
NCT03301480 |
|
ContraceptiveHIV Affecting Risk in Adolescents
|
View
|
NCT05471076 |
|
Trial to Evaluate the Safety and Immunogenicity of Priming Regimens of 426cModCore-C4b and Optional Boost Regimen With HIV Trimer BG505 SOSIPGT11 gp140 Both Adjuvanted With 3M-052-AF Alum in Healthy Adult Participants Without HIV
|
View
|
NCT00011011 |
|
Vaccine ALVAC-HIV vCP1452 Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV
|
View
|
NCT02291809 |
|
REMUNE HIVAIDS Vaccine Phase II Pediatric Safety Efficacy Clinical Study
|
View
|
NCT02304354 |
|
Relationship Between T LYmphocytes Depletion and Clinical Response to RITUXimab in Rheumatoid Arthritis LYRITUX
|
View
|
NCT02316444 |
|
Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda
|
View
|
NCT05525156 |
|
The Effect of Aspirin on HIV Disease Progression Among HIV- Infected Individuals Initiating Anti- Retroviral Therapy
|
View
|
NCT05529342 |
|
Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product AGT103-T
|
View
|
NCT05528952 |
|
Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
|
View
|
NCT02366026 |
|
REMUNE AMPLIVAX IR103 HIVAIDS Phase III Safety Efficacy Study
|
View
|
NCT05540964 |
|
An Antiretroviral Treatment Interruption ATI Study to Evaluate the Impact of Genetically Modified Autologous Cells AGT103-T to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy
|
View
|
NCT02389595 |
|
Selection of a Protective T Cell-based HIV-1FIV Vaccine
|
View
|
NCT02396355 |
|
Accuracy Evaluation of the BD FACS Presto System
|
View
|
NCT03519464 |
|
Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia
|
View
|
NCT02429869 |
|
Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant
|
View
|
NCT05582694 |
|
A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection
|
View
|
NCT05580458 |
|
Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population
|
View
|
NCT02519413 |
|
Tecfidera Lymphocyte Chart Review
|
View
|
NCT02515149 |
|
Impact on Linkage to HIV Care With Point of Care CD4 Testing and Home-based HIV Testing in Kenya
|
View
|
NCT03561402 |
|
Biomarkers and Disease Activity in Patients Treated With Teriflunomide Aubagio
|
View
|
NCT00002307 |
|
A Comparison of Zidovudine AZT and Stavudine in HIV-Infected Patients
|
View
|
NCT05635435 |
|
Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Correlate With Grades and Subtypes
|
View
|
NCT00016783 |
|
Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV
|
View
|
NCT05648136 |
|
Immune Profile Analysis and Biomarker Identification in Women With Repeated Implantation Failure or Unexplained Recurrent Spontaneous Miscarriage
|
View
|
NCT03572556 |
|
Prospective Descriptive Study of the Angiogenic T Cell Population in Subjects With Hereditary Hemorrhagic Telangiectasia HHT
|
View
|
NCT03577782 |
|
Vedolizumab Treatment in HIV-Infected Subjects Without Previous Antiretroviral Therapy
|
View
|
NCT03735823 |
|
IL-11 in the Development of Multiple Sclerosis
|
View
|
NCT02581956 |
|
Walking Affecting Immunology and Quality of Life of Breast Cancer Patients
|
View
|
NCT05687565 |
|
Efficacy of Lauric Acid a Dietary Fatty Acid in Modifying the Latent Reservoir of HIV
|
View
|
NCT03600025 |
|
Cellular Immune Responses in Typhoid Fever Patients and Vaccinees
|
View
|
NCT03601611 |
|
Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease Mechanisms
|
View
|
NCT03823261 |
|
Effects of a Nurse-delivered Cognitive Behaviour Therapy on Adherence and Depressive Symptoms in HIV Infected Persons of South Korea
|
View
|
NCT00014053 |
|
A Study of Immune System Activity in Healthy Adults
|
View
|
NCT02656511 |
|
Immediate Initiation of Antiretroviral Therapy During Hyperacute HIV Infection
|
View
|
NCT02659800 |
|
Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas
|
View
|
NCT05727410 |
|
Neoadjuvant Nivolumab Docetaxel Cisplatin Therapy Followed by Surgery and Radiation Therapy for Resectable High Grade Salivary Gland Carcinoma
|
View
|
NCT03629327 |
|
Inducing Immune Quiescence the Genital Tract With ASA
|
View
|
NCT03767465 |
|
Treatment With Immunological Checkpoint Inhibitors of HIV-infected Subjects With Cancer
|
View
|
NCT02705703 |
|
Consolidation Therapy in Patients With Metastatic Solid Malignancies
|
View
|
NCT03633110 |
|
Safety Tolerability Immunogenicity and Antitumor Activity of GEN-009 Adjuvanted Vaccine
|
View
|
NCT05757310 |
|
A Reduced-Intensity Conditioning Regimen Cyclophosphamide Pentostatin Anti-thymocyte Globulin Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia
|
View
|
NCT03774108 |
|
Metformin and Systemic Inflammation in HIV
|
View
|
NCT05768880 |
|
Study of B7-H3 EGFR806 HER2 And IL13-Zetakine Quad CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma Diffuse Midline Glioma And Recurrent Or Refractory Central Nervous System Tumors
|
View
|
NCT02732054 |
|
Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell Counts
|
View
|
NCT05780073 |
|
Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment
|
View
|
NCT02775084 |
|
Fish Oil T Cell Function
|
View
|
NCT03663920 |
|
HIV Infection and Risk Related CoinfectionsComorbidities in Indonesia
|
View
|
NCT02793765 |
|
Docetaxel Followed by Provenge in Metastatic Prostate Cancer
|
View
|
NCT03880006 |
|
Universal Coverage of Antiretroviral Treatment in Senegal
|
View
|
NCT04280848 |
|
Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma
|
View
|
NCT02837757 |
|
Everolimus Modulation of Anti-tumor T CD4 Immune Responses
|
View
|
NCT02831764 |
|
An Efficacy Safety and Tolerability Study Comparing Dolutegravir DTG Plus Lamivudine 3TC With Dolutegravir Plus TenofovirEmtricitabine in Treatment naïve HIV Infected Participants Gemini 2
|
View
|
NCT02843841 |
|
Polyclonal Antilymphocyte Globulin ATG Intestinal Immune Barrier After Kidney Transplantation
|
View
|
NCT00001036 |
|
The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection
|
View
|
NCT05852301 |
|
Optimising Cohorts for HIV Cure Interventions
|
View
|
NCT02859558 |
|
Early ART to Limit Infection and Establishment of Reservoir
|
View
|
NCT02854644 |
|
Study of the Anti-tumoral Immune Response
|
View
|
NCT05872659 |
|
Mesenchymal Stem Cells for Immune Non-responder Patients With HIV Infection
|
View
|
NCT02929992 |
|
Delivery Optimization for Antiretroviral Therapy The DO ART Study
|
View
|
NCT04451980 |
|
The HIV Adipose Tissue Immunology and Metabolism Study
|
View
|
NCT02935296 |
|
Integrated Treatment and Prevention for People Who Inject Drugs
|
View
|
NCT02383797 |
|
Immunodeficiency in Cartilage-hair Hypoplasia Sub-project on Safety of Vaccination Against Chickenpox
|
View
|
NCT02964767 |
|
HIV-Tb Confections Among HIV Patients
|
View
|
NCT04320667 |
|
Urinary T Cell Biomarker for Prediction in ANCA Glomerulonephritis
|
View
|
NCT05362812 |
|
Prediction of Lupus Renal Flares Study
|
View
|
NCT02614950 |
|
Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection
|
View
|
NCT03009149 |
|
Effects of Aerobic Exercise on CD4 CountViral LoadSelected Psycho-social Trait
|
View
|
NCT03020524 |
|
Autologous CD4 T-Cells in HIV C34-CXCR4
|
View
|
NCT03033368 |
|
Rilpivirine in Virologically Suppressed Adolescents
|
View
|
NCT00574652 |
|
Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-related Vasculitis Patients
|
View
|
NCT04361422 |
|
Isotretinoin in Treatment of COVID-19
|
View
|
NCT03113773 |
|
Low Dose Interleukin-2 in Patients With Stable Ischaemic Heart Disease and Acute Coronary Syndromes
|
View
|
NCT01837277 |
|
Impact of a Dolutegravir-based Regimen on Early Mortality of AIDS Patients
|
View
|
NCT03122106 |
|
Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
|
View
|
NCT04373980 |
|
Conventional Versus LED Phototherapy and Their Effect on Lymphocytes Subsets of Full Term Neonates With Hyperbilirubinemia
|
View
|
NCT04500678 |
|
Impact of Metformin on Immuno-virologic Parameters in HIV
|
View
|
NCT01836003 |
|
An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
|
View
|
NCT04515225 |
|
COVID-19 Prevalence in HIV-infected Patients
|
View
|
NCT03203369 |
|
Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN
|
View
|
NCT04402892 |
|
COVID-19 SARS-CoV-2 Specific Memory B and T-CD4 Cells
|
View
|
NCT03249831 |
|
A Blood Stem Cell Transplant for Sickle Cell Disease
|
View
|
NCT06094842 |
|
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer
|
View
|
NCT06094998 |
|
Health Status of Children Born After Assisted Reproductive Technologies
|
View
|
NCT06105021 |
|
Phase I Study of Autologous CD8 and CD4 Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor
|
View
|
NCT04428398 |
|
Urinary T Lymphocytes Predict Renal Flares in Patients With Inactive ANCA-associated Glomerulonephritis
|
View
|
NCT04588051 |
|
Cabozantinib in Hepatocellular Carcinoma
|
View
|
NCT03284970 |
|
Retrospective Study to Determine Effect of Rebif and Tecfidera on Infections and Lymphocytes
|
View
|
NCT03298360 |
|
A Chronological Study of the Formation of HIV Cellular Reservoirs Through the Expression of Surface Markers on CD4 T Lymphocytes Including CD32a
|
View
|
NCT03308786 |
|
HIV Reservoir Reduction With Interleukin-2
|
View
|
NCT03326921 |
|
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
|
View
|
NCT01839734 |
|
Lubiprostone as a Modulator of Gut Microbial Translocation in HIV With Incomplete CD4 Recovery on Antiretroviral Therapy
|
View
|
NCT06141369 |
|
Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine mRNA-0523-L001
|
View
|
NCT03368053 |
|
Long-term Immunogenicity of the HIV gp120-NefTatAS01B Vaccine GSK SB732461
|
View
|
NCT01838915 |
|
Randomized Placebo-controlled Pilot Trial of PrebioticsGlutamine in HIV Infection
|
View
|
NCT03412071 |
|
Effect of Antibiotics on Penile Microbiome and HIV Susceptibility Study in Ugandan Men
|
View
|
NCT04645147 |
|
Safety and Immunogenicity of an Epstein-Barr Virus EBV gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection
|
View
|
NCT04648046 |
|
CAR-T Cells for HIV Infection
|
View
|
NCT03478540 |
|
Gut Microbiota and Immune Recovery
|
View
|
NCT06256341 |
|
HHV-6-specific T-cell Reconstitution Among Children and Adolescents After Allogeneic Stem
|
View
|
NCT03542786 |
|
Clinical Trial to Evaluate the Addition to an Antiretroviral Treatment of a Probiotic
|
View
|
NCT03559803 |
|
A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer
|
View
|
NCT00000756 |
|
Evaluation of the Safety and Tolerance of Immunotherapy With Autologous Ex-Vivo Expanded HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4 Counts Between 100-400mm3
|
View
|
NCT04836793 |
|
COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2
|
View
|
NCT04697407 |
|
IL-2 Signaling and Polarization of Regulatory LBs Involvement in Multiple Sclerosis
|
View
|
NCT01845298 |
|
Immune Activation and Drug Absorption in HIV-Infected Patients
|
View
|
NCT03593187 |
|
A Study Evaluating the Safety of Cal-1 LVsh5C46 Drug Product in HIV-1 Infected Patient With High Risk Lymphoma
|
View
|
NCT04706143 |
|
Immunologic Responses to Single and Double Doses of COVID-19 Vaccines in Egyptians
|
View
|
NCT03617198 |
|
CD4 CAR ZFN-modified T Cells in HIV Therapy
|
View
|
NCT04713046 |
|
Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16 Cancers
|
View
|
NCT04914143 |
|
the Effect of Broken Ganoderma Lucidum Spore Powder on Quality of Life and Immune Function in Patients With Diffuse Large B-cell Lymphoma After Chemotherapy
|
View
|
NCT00005779 |
|
Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 IL-12 in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy
|
View
|
NCT04880395 |
|
Dolutegravir-Lamivudine for naïve HIV-Infected Patients With 200 CD4mm3
|
View
|
NCT04884867 |
|
A Psychosocial Tele-health Stigma Intervention for Youth Living With HIV in Vietnam
|
View
|
NCT06405958 |
|
Gut Microbiome Analysis in Organ Transplant Recipient
|
View
|
NCT03829540 |
|
CD4CAR for CD4 Leukemia and Lymphoma
|
View
|
NCT04950101 |
|
Prevalence of Anal High-risk Human Papilloma Virus Infection and Abnormal Anal Cytology in Men Who Have Sex With Men Using Pre Exposure Prophylaxis
|
View
|
NCT03842488 |
|
Raltegravir One Thousand Two Hundred vs Darunavir-cb in Immnunosupressed Patients ROTDIP Study
|
View
|
NCT03879993 |
|
Resistance Training in People Living With HIVAIDS
|
View
|
NCT04963712 |
|
Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder
|
View
|
NCT04973527 |
|
LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4 T Lymphocyte Tumor
|
View
|
NCT03927053 |
|
Consequences of Marijuana Use in HIV-infected Youth
|
View
|
NCT03946358 |
|
Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers VolATIL
|
View
|
NCT03956056 |
|
Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
|
View
|
NCT05126927 |
|
A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 T Cells in Patients With Solid Tumors
|
View
|
NCT03993093 |
|
Prevalence of HIV ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre
|
View
|
NCT04219319 |
|
LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4 T-cell Lymphoma
|
View
|
NCT05049187 |
|
Characterization and Durability of COVID-19 Vaccine Induced Immune Responses in HealthcareFrontline Workers
|
View
|
NCT04136106 |
|
The Incidence of Infection in Treatment of Low-dose IL-2 of SLE Patients
|
View
|
NCT05220358 |
|
Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study
|
View
|
NCT04162340 |
|
CD4-specific CAR T Cells CD4 CAR T Cells for RelapsedRefractory T Cell Malignancies
|
View
|
NCT04173819 |
|
Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies 3BNC117-LS-J and 10-1074-LS-J in Healthy American and African Adults
|
View
|
NCT04192487 |
|
Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV Patients With Non-Infectious Diarrhea
|
View
|
NCT04224597 |
|
Evaluation of the Presence of Enthesitis in Patients With Acne Vulgaris
|
View
|
NCT04247217 |
|
Immune Profiling After HDR in Local Relapsed Prostate Cancer
|
View
|
NCT04269265 |
|
The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination
|
View
|
NCT04295460 |
|
Triple vs Double Therapy in naïves HIV-Infected Patients
|
View
|
NCT04311593 |
|
Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura
|
View
|
NCT02396394 |
|
Improving ART Retention and Adherence in Uganda The WiseMama Study
|
View
|
NCT04342962 |
|
Tagraxofusp in Patients With CD123 or With BPDCN-IPh-like Acute Myeloid Leukemia
|
View
|
NCT01860807 |
|
Trial of Ibudilast for Methamphetamine Dependence
|
View
|
NCT00929604 |
|
HIV Viral Load Monitoring in Resource-Poor Settings
|
View
|
NCT00134602 |
|
Pediatric Impact Promoting Adherence to Medications Among HIV-infected Children
|
View
|
NCT04517825 |
|
More Than a Machine Make Point-of-care HIV-1 Viral Load Testing Effective in Rural Uganda
|
View
|
NCT02388594 |
|
A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients
|
View
|
NCT04566276 |
|
ChulaCov19 Vaccine in Healthy Adults
|
View
|
NCT00001136 |
|
A Study of the Effectiveness of an HIV Vaccine ALVAC vCP205 to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine
|
View
|
NCT05950308 |
|
Assessment of Immune Response in Multiple Sclerosis Patients With COVID-19Vaccination Treated With Ofatumumab and Other Disease Modifying Therapies
|
View
|
NCT00002086 |
|
A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir AZT and HIVID ddC Versus Retrovir HIVID and Wellferon Interferon Alfa-n1 for the Treatment of HIV Infection
|
View
|
NCT04639245 |
|
Genetically Engineered Cells MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer Urothelial Cancer or Non-small Cell Lung Cancer
|
View
|
NCT05838599 |
|
Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides
|
View
|
NCT01869595 |
|
Thai MSMTG Test and Treat Study
|
View
|
NCT04712864 |
|
Study of CD4-Targeted Chimeric Antigen Receptor T-Cells CD4- CAR-T in Subjects With Relapsed or Refractory T-Cell Lymphoma
|
View
|
NCT05984394 |
|
Evaluation of Antigen-specific T Cells in Patients With Antisynthetase Syndrome and Interstitial Lung Disease
|
View
|
NCT04738812 |
|
Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression
|
View
|
NCT04761653 |
|
Study of the Inflammatory Microenvironment in Atypical Meningiomas
|
View
|
NCT04779359 |
|
Role of Lymphocyte Subsets and Laboratory Measurements in COVID-19 Disease
|
View
|
NCT01872390 |
|
Start TB Patients on ART and Retain on Treatment START Study
|
View
|
NCT04798651 |
|
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
View
|
NCT04847388 |
|
Prevalence of Substance Abuse Among Anti-retroviral Treatment Naive Patients Positive for HIV Antibodies
|
View
|
NCT04873492 |
|
From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis
|
View
|
NCT01874743 |
|
Rosuvastatin to Decrease Residual Immune Activation in HIV Infection
|
View
|
NCT01529554 |
|
Controlled Level EVERolimus in Acute Coronary Syndromes
|
View
|
NCT00617526 |
|
Naïve HIV POC Monotherapy Trial
|
View
|
NCT00055237 |
|
Bevacizumab to Treat Kaposis Sarcoma in HIV-Positive and HIV-Negative Patients
|
View
|
NCT00276991 |
|
Traditional CAM Therapy in the Treatment of HIVAIDS
|
View
|
NCT00002171 |
|
A Study of Viracept in HIV-Positive Women
|
View
|
NCT00002214 |
|
Phase I Trial of S-1153 in Patients With HIV Infection
|
View
|
NCT05045417 |
|
IL17 in Systemic Lupus Erythematosus Patients Association With Disease Activity and Organ Damage
|
View
|
NCT00002254 |
|
A Multi-Center Open-Label Ascending Multiple Oral Dose Safety Tolerance and Pharmacokinetic Study of 3-Deoxy-3-Fluorothymidine FLT in Patients With Acquired Immune Deficiency Syndrome AIDS or AIDS-Related Complex ARC
|
View
|
NCT05089110 |
|
Expression of Toll-like Receptors 3 7 and 9 in Peripheral Blood Mononuclear Cells of COVID-19 Patients
|
View
|
NCT05085171 |
|
An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
|
View
|
NCT01184456 |
|
A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
|
View
|
NCT01881581 |
|
Safety and Immunogenicity of Recombinant HIV Vaccines for HIVAIDS
|
View
|
NCT01882010 |
|
Leukine Sargramostim for Parkinsons Disease
|
View
|
NCT05222035 |
|
PD-1 Inhibitor Plus G-CSF in RecurrentMetastatic NPC With First-line Treatment Failure
|
View
|
NCT06205511 |
|
The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV
|
View
|
NCT00002165 |
|
Viracept Expanded Access Program
|
View
|
NCT02345135 |
|
Susceptibility to Infections in Ataxia Telangiectasia
|
View
|
NCT01901016 |
|
Relaxation Depressive Symptoms Quality of Life in People Living With HIV a Pilot Study
|
View
|
NCT06655831 |
|
Key Mechanisms of Abnormal T Cell Activation and Differentiation in IgG4-Related Ophthalmic Disease
|
View
|
NCT06554210 |
|
Epidemiological Study of the Markers of Aging in the Cohort of Patient HIV in Brest
|
View
|
NCT01900080 |
|
Same-Day HIV Testing and Treatment Initiation to Improve Retention in Care
|
View
|
NCT06504485 |
|
Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection Outcomes and Response to Bulevirtide Treatment
|
View
|
NCT00145795 |
|
A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment
|
View
|
NCT00001057 |
|
The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients
|
View
|
NCT06612554 |
|
Zn Supplementation in HIV Immunological Non Responders
|
View
|
NCT00614640 |
|
Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children Adolescents and Young Adults
|
View
|
NCT00000831 |
|
Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy
|
View
|
NCT00004736 |
|
Effectiveness of Anti-HIV Therapy HAART in HIV-Infected Patients With Tuberculosis
|
View
|
NCT01923116 |
|
Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
|
View
|
NCT00999739 |
|
Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults
|
View
|
NCT00002379 |
|
The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
|
View
|
NCT01928407 |
|
Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts
|
View
|
NCT00000391 |
|
A Phase I Trial of Intranasal Peptide T Safety Toxicity and Pharmacokinetics in Human Immunodeficiency Virus-1 HIV-1 Infected Patients
|
View
|
NCT00002197 |
|
A Study of 1592U89 in HIV-Infected Children
|
View
|
NCT01924286 |
|
Preventing TB-IRIS in High-risk Patients a Randomized Placebo-controlled Trial of Prednisone
|
View
|
NCT01935089 |
|
Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV
|
View
|
NCT00001131 |
|
Effectiveness of Interleukin-2 IL-2 Plus Anti-HIV Therapy in HIV-Positive Patients
|
View
|
NCT00636935 |
|
Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia PCP
|
View
|
NCT01930084 |
|
ENGAGE4HEALTH A Combination Intervention Strategy for Linkage and Retention in Mozambique
|
View
|
NCT00015704 |
|
Effect of Interleukin-2 on HIV Treatment Interruption
|
View
|
NCT00000642 |
|
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G rCD4-IgG in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns
|
View
|
NCT05576961 |
|
Safety and Efficacy of RX-af01 Combined With PD-1 Antibody
|
View
|
NCT01950325 |
|
VRC 601 A Phase I Open-Label Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody VRC HIVMAB060-00-AB VRC01 With Broad HIV-1 Neutralizing Activity Administered Intravenously or Subcutaneously to HIV-Infected
|
View
|
NCT01965470 |
|
Botswana Combination Prevention Project
|
View
|
NCT01969058 |
|
Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4 T Cell Recovery
|
View
|
NCT06525389 |
|
Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis LAmB-FAST
|
View
|
NCT00002376 |
|
The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients
|
View
|
NCT01996774 |
|
Immunologic Profile of Children With Severe Allergies to Peanuts and Nuts After Induction of Tolerance
|
View
|
NCT00751595 |
|
Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine
|
View
|
NCT05672654 |
|
Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised Patients
|
View
|
NCT06582992 |
|
DNA Methylation Trajectories in Aging
|
View
|
NCT00042406 |
|
Trial With HuMax-CD4 in Participants With Rheumatoid Arthritis RA Failing Treatment With Methotrexate MTX and a TNF-alpha Blocker
|
View
|
NCT00002435 |
|
A Study of Thymic Humoral Factor THF Gamma 2 in HIV-Infected Patients
|
View
|
NCT05698342 |
|
Tissue-resident Memory T Cells Expression in Melasma
|
View
|
NCT00002177 |
|
A Pilot Open Label Trial of HIV Therapy With d4T Stavudine ddI Didanosine Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection
|
View
|
NCT00002032 |
|
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex MAC Bacteremia in AIDS Patients With CD4 Counts or 200 A Double-Blind Placebo-Controlled Trial
|
View
|
NCT02004314 |
|
Chloroquine as a Modulator of T Cell Immune Activation
|
View
|
NCT00067704 |
|
Emotional Disclosure in HIV
|
View
|
NCT02018965 |
|
Niacin on Immune Activation a Proof-of-concept Study
|
View
|
NCT00817752 |
|
Ashwagandha Effects on Stress Inflammation and Immune Cell Activation
|
View
|
NCT00000625 |
|
A Randomized Double-Blind Phase IIIII Trial of Monotherapy vs Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500mm3
|
View
|
NCT00157027 |
|
RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy HAART
|
View
|
NCT00002161 |
|
A Multi-Center Randomized Double-Blind Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts 200mm3
|
View
|
NCT03549546 |
|
Expression of the Inhibitory Receptors on Lymphocytes T Cells After Lung Cancer Surgery
|
View
|
NCT02025322 |
|
A Pilot Study to Examine Efficacy of Peer Mentoring in Promoting Medication Adherence Among People Living With HIVAIDS
|
View
|
NCT02028676 |
|
Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa
|
View
|
NCT02624453 |
|
Pre-Antiretroviral Therapy ART Cryptococcal Antigen Screening in AIDS
|
View
|
NCT00000844 |
|
A Multicenter Prospective Randomized Double-Blind Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4 Counts 50 and 350 Cellsmm3
|
View
|
NCT00050284 |
|
Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection
|
View
|
NCT02042248 |
|
A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004
|
View
|
NCT00904254 |
|
The Use of Anti-CD4 mAb-Fragment for Imaging of Local Inflammation in Patients With Carotid Artery Stenosis
|
View
|
NCT00118677 |
|
Long-Term Supervised Treatment Interruption in HIV-Infected Patients
|
View
|
NCT00917813 |
|
A Study of Anti-HIV Monoclonal Antibody KD-247
|
View
|
NCT00152061 |
|
The Switch Study The Role of LamivudineEmtricitabine 3TCFTC in Antiretroviral Regimens
|
View
|
NCT00120419 |
|
Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 MAN2 Study
|
View
|
NCT00120510 |
|
Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti
|
View
|
NCT00296972 |
|
Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication
|
View
|
NCT00137657 |
|
Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance
|
View
|
NCT00000825 |
|
The Effects of Giving Interleukin-2 IL-2 Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cellsmm3
|
View
|
NCT00002095 |
|
A Randomized Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus
|
View
|
NCT05898464 |
|
Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV
|
View
|
NCT05916261 |
|
Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer
|
View
|
NCT05916248 |
|
Personalized Tumor Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors
|
View
|
NCT00999622 |
|
Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma
|
View
|
NCT00148824 |
|
Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults
|
View
|
NCT02054494 |
|
T1 Mapping in HIV Patients With High and Low CD4 Cell Counts
|
View
|
NCT05977010 |
|
Evaluation of GeneXpert HIV-1 as The Gold Standard Test for HIV-1 Viral Load Count
|
View
|
NCT00000802 |
|
A Randomized Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim andor Sulfonamides
|
View
|
NCT00100581 |
|
Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCVHIV Infected Adults
|
View
|
NCT00002079 |
|
Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin SC-48334 and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4 Cellsmm3 NOTE Asymptomatic HIV-1 Infected Patients Also Eligible
|
View
|
NCT01050296 |
|
Molecular Analysis Of Solid Tumors
|
View
|
NCT00000883 |
|
Long-Term Assessment for Metabolic Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy
|
View
|
NCT00002200 |
|
A Study of 1592U89 in HIV-Infected Adults
|
View
|
NCT00295477 |
|
Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV
|
View
|
NCT00000728 |
|
Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy
|
View
|
NCT06044792 |
|
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
View
|
NCT02057796 |
|
Systematic Empirical vs Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts 100mm3
|
View
|
NCT06071624 |
|
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 CD4CARas a Second Line Treatment for Chronic Myelomonocytic Leukemia CMML
|
View
|
NCT00051831 |
|
Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults
|
View
|
NCT00144170 |
|
TipranavirRitonavir vs Genotypically Defined Protease InhibitorRitonavir in HIV Patients RESIST-2
|
View
|
NCT01190124 |
|
Raltegravir With Optimized Background Therapy OBT in Multiple Experienced HIV-infected Patients
|
View
|
NCT01202305 |
|
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
|
View
|
NCT01204905 |
|
R5 Integrase Study in HIV-1 Naive Patients
|
View
|
NCT06197672 |
|
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia AML as a Bridge to Allogeneic Stem Cell Transplant
|
View
|
NCT01228578 |
|
Multi-vitamins HAART and HIVAIDS in Uganda
|
View
|
NCT00002390 |
|
A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients
|
View
|
NCT00000805 |
|
A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
|
View
|
NCT01269515 |
|
Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients
|
View
|
NCT00001029 |
|
A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past
|
View
|
NCT01296373 |
|
A Study to Explore Reconstitution of Immunity in Patients With Advanced HIV-1-infection
|
View
|
NCT00000947 |
|
A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients
|
View
|
NCT00000907 |
|
A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex DMAC in HIV-Positive Patients
|
View
|
NCT00002338 |
|
The Safety and Effectiveness of 935U83 in HIV-Infected Patients
|
View
|
NCT00001069 |
|
A Study of Two Methods of Determining When to Begin or Change Anti-HIV Treatment
|
View
|
NCT00108862 |
|
Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis
|
View
|
NCT00162500 |
|
A Novel Vaccine for the Treatment of MUC1-expressing Tumor Malignancies
|
View
|
NCT01392430 |
|
Discontinuation of Primary and Secondary Prophylaxis for Opportunistic Infections in HIV-infected Patients
|
View
|
NCT06399783 |
|
Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata
|
View
|
NCT01425073 |
|
Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya
|
View
|
NCT06427421 |
|
Characterization of Autoreactive Regulatory and Conventional CD4 T Cells in Recent Onset Type 1 Diabetes and Control Individuals
|
View
|
NCT00000696 |
|
A Phase III Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease
|
View
|
NCT06444152 |
|
Prevalence of Epstein-Barr Virus Infection
|
View
|
NCT01455688 |
|
Early Antiviral Therapy for Critically Ill HIV Infected Patients
|
View
|
NCT01450059 |
|
Maternal-fetal CD4 Microchimerism in HiV Exposed Newborns After Spontaneous Delivery and Cesarean Section
|
View
|
NCT01466595 |
|
Rifaximin as a Modulator of Microbial Translocation and Immune Activation
|
View
|
NCT00215852 |
|
A Randomized Dose-ranging Study of Alferon LDO in Asymptomatic HIV Subjects
|
View
|
NCT00002092 |
|
A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection
|
View
|
NCT00000914 |
|
A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks
|
View
|
NCT00002196 |
|
A Study of CI-1012 in HIV-Infected Patients
|
View
|
NCT00002084 |
|
A Comparative Trial of Valacyclovir Hydrochloride 256U87 and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
|
View
|
NCT00000979 |
|
Comparison of ddI Versus Zidovudine in HIV-Infected Patients
|
View
|
NCT00119093 |
|
Home-based AIDS Care Project
|
View
|
NCT06496373 |
|
Clinical Study of XP-004 Personalized mRNA Tumor Vaccine Combined With PD-1 Inhibitor for Postoperative Adjuvant Therapy for Pancreatic Cancer in Patients With Advanced Solid Tumors
|
View
|
NCT00002334 |
|
A Study of Zidovudine AZT Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment
|
View
|
NCT00000923 |
|
Treatment With Interleukin-2 IL-2 Plus Combination Anti-HIV-Drug Therapy HAART for Patients Formerly in ACTG 328
|
View
|
NCT00000889 |
|
A Study to Evaluate the Effects of Giving Interleukin-2 IL-2 Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cellsmm3
|
View
|
NCT00000671 |
|
A Phase II Efficacy Study Comparing 23-Dideoxyinosine ddI BMY-40900 and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
|
View
|
NCT00000743 |
|
A Phase I Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons
|
View
|
NCT00000651 |
|
A Randomized Double Blind Comparative Study of Dideoxycytidine ddC Alone or ddCAZT Combination Versus Zidovudine ZDV Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy
|
View
|
NCT00000755 |
|
A Phase III Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cellsmm3
|
View
|
NCT00000949 |
|
A Study to Evaluate the Effects of Giving Proleukin rIL-2 to HIV-Positive Patients With CD4 Counts Greater Than 300 Cellsmm3
|
View
|
NCT00002309 |
|
A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease MAC in HIV-Infected Patients
|
View
|
NCT00000908 |
|
A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts
|
View
|
NCT02070900 |
|
Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment ART in HIV Positive Pregnant Women in the Context of Option B for PMTCT
|
View
|
NCT06043713 |
|
Autologous CD8 and CD4 Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors FH-A11KRASG12V-TCR in Treating Patients With Metastatic Pancreatic Colorectal and Non-Small Cell Lung Cancers With KRAS G12V Mutations
|
View
|
NCT00000820 |
|
A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy
|
View
|
NCT00002173 |
|
An Expanded Access Open Label Protocol of Remune HIV-1 Immunogen in HIV-1-Infected Adults With CD4 Count 550 Cells Ml and Greater
|
View
|
NCT00000932 |
|
A Study of the Long-Term Outcomes of HIV-Positive Patients
|
View
|
NCT00002325 |
|
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
|
View
|
NCT00224458 |
|
Combination of Efavirenz and Truvada - COMET Study
|
View
|
NCT00002333 |
|
A Study of Saquinavir and Zalcitabine Used Alone and Together in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine
|
View
|
NCT00000729 |
|
A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL andor Constitutional Disease
|
View
|
NCT00004855 |
|
Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
|
View
|
NCT00270296 |
|
Trizivir Vs Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV
|
View
|
NCT00000841 |
|
A Study of Indinavir Sulfate Plus Zidovudine AZT Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months
|
View
|
NCT00002451 |
|
Safety and Effectiveness of Giving Indinavir Ritonavir Stavudine and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
|
View
|
NCT00000821 |
|
Subcutaneously Administered Aldesleukin Interleukin-2 IL-2 Therapy in HIV-Infected Patients
|
View
|
NCT00238459 |
|
Controlling Acute or Early HIV Infection With Antiretroviral Drugs Without a Candidate VaccineAs Reported Previously the Candidate Vaccie Was Not Provided by the Maufacturer as Promised
|
View
|
NCT00002369 |
|
A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
|
View
|
NCT00654147 |
|
Raltegravir LopinavirRitonavir or EmtricitabineTenofovir for HIV Treatment Naive Subjects
|
View
|
NCT02097381 |
|
Study of Recovery of Intestinal CD4 and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy
|
View
|
NCT00002312 |
|
The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine
|
View
|
NCT00002168 |
|
A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
|
View
|
NCT00002324 |
|
The Safety and Effectiveness of Nevirapine and Zidovudine Given Separately and Together in HIV-1 Infected Patients Who Have No Symptoms of the Disease
|
View
|
NCT00000876 |
|
Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children
|
View
|
NCT00002233 |
|
A Study of a Combination of Four Drugs in Patients With Recent HIV Infection
|
View
|
NCT00002322 |
|
A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients
|
View
|
NCT00000909 |
|
A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cellsmm3 Who Do Not Wish to Receive Anti-HIV Therapy
|
View
|
NCT02098837 |
|
Cardiovascular Risk in HIV Patients Switching From a Boosted Protease Inhibitor PI to Dolutegravir DTG
|
View
|
NCT00005012 |
|
Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
|
View
|
NCT03940521 |
|
Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4 T Cells of Adults Undergoing Treatment
|
View
|
NCT00271856 |
|
Staying Well A Clinical Trial of Mindfulness-Based Stress Reduction and Education Groups for HIV
|
View
|
NCT00772590 |
|
Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4 T Cell Response
|
View
|
NCT00197652 |
|
Botswana Diarrheal Diseases Study
|
View
|
NCT01071031 |
|
HIV Vaccine Study in HIV Positive Patients
|
View
|
NCT00735072 |
|
Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure
|
View
|
NCT02117518 |
|
Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients
|
View
|
NCT00784147 |
|
Dose-Response Study of Ibalizumab Monoclonal Antibody Plus Optimized Background Regimen in Patients With HIV-1
|
View
|
NCT00000639 |
|
A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis
|
View
|
NCT00786396 |
|
Directly Observed Therapy for Community-Released HIV Prisoners
|
View
|
NCT00000704 |
|
A Multicenter Dose Ranging Clinical Trial of 23-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC
|
View
|
NCT00000824 |
|
A Study of Cytotoxic T Lymphocyte CTL Therapy in HIV-Infected Patients
|
View
|
NCT00002129 |
|
A Phase I Study of Three Doses of OPC-8212 Vesnarinone in HIV-Infected Persons With CD4 Cell Number 300 Cellsmm3
|
View
|
NCT00000905 |
|
A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus CMV Retinitis After Effective Anti-HIV Therapy
|
View
|
NCT02135003 |
|
Non-enrolment and Non-adherence to HIV Care in a Community-based Program Rakai Uganda
|
View
|
NCT00001105 |
|
The Safety and Effectiveness of Human Monoclonal Antibody F105 in the Treatment of HIV
|
View
|
NCT00000977 |
|
Active Immunization of Asymptomatic HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen A Phase III Study of Immunogenicity and Toxicity
|
View
|
NCT00027352 |
|
A Comparison of Two Ways to Manage Anti-HIV Treatment The SMART Study
|
View
|
NCT00002236 |
|
A Study to Find the Best Dosing Schedule for Delavirdine Zidovudine and Indinavir in HIV-Positive Patients
|
View
|
NCT05349591 |
|
CePolyTregs in Islet Transplantation
|
View
|
NCT00006291 |
|
Safety and Effectiveness of Adding Either an HIV Vaccine Interleukin-2 or Both to a Patients Anti-HIV Drug Combination
|
View
|
NCT03723525 |
|
Package of Care to Improve Retention in ART and Mortality Among Treatment Naive HIV Infected Individuals
|
View
|
NCT00000955 |
|
Two-Stage Tuberculin PPD Skin Testing in Individuals With Human Immunodeficiency Virus HIV Infection
|
View
|
NCT04473365 |
|
Rapid Diagnostic Profiling of SARS-CoV-2 COVID-19
|
View
|
NCT05275998 |
|
TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals
|
View
|
NCT00000850 |
|
The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy
|
View
|
NCT00000948 |
|
Effects of Giving Interleukin-2 IL-2 Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cellsmm3
|
View
|
NCT05244473 |
|
A Safety Study of Brentuximab Vedotin in Participants With HIV
|
View
|
NCT01407211 |
|
Impact of Vitamin A on Gene Expression in Multiple Sclerosis Patient
|
View
|
NCT00002389 |
|
The Safety and Effectiveness of Lamivudine Plus Zidovudine Used With and Without 1592U89 in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs
|
View
|
NCT02158208 |
|
Study of the T CD8 Immune Response in Hortons Disease
|
View
|
NCT03028987 |
|
Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection SLVP031
|
View
|
NCT00190242 |
|
Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients
|
View
|
NCT02707861 |
|
Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1
|
View
|
NCT02153918 |
|
Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy
|
View
|
NCT02590354 |
|
Analytical Treatment Interruption in HIV Positive Patients
|
View
|
NCT02079077 |
|
Inducing Immune Quiescence to Prevent HIV Infection in Women
|
View
|
NCT01766076 |
|
Atorvastatin for HAART Suboptimal Responders
|
View
|
NCT00000984 |
|
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 rCD4 in Infants and Children Infected With or at Risk for HIV Infection
|
View
|
NCT00001045 |
|
Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease
|
View
|
NCT00002005 |
|
A Phase I Study of Recombinant CD4rCD4 in Patients With AIDS and AIDS-Related Complex
|
View
|
NCT04415424 |
|
Efficacy Study of 4CMenB Bexsero to Prevent Gonorrhoea Infection in Gay and Bisexual Men
|
View
|
NCT00002203 |
|
A Study of Two Anti-HIV Drug Combinations
|
View
|
NCT00000943 |
|
A Study to Test If Giving Remune an HIV Vaccine Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328
|
View
|
NCT01633476 |
|
CMV Modulation of the Immune System in ANCA-associated Vasculitis
|
View
|
NCT01267643 |
|
Alefacept in Patients With RelapsedRefractory Aplastic Anemia
|
View
|
NCT00004816 |
|
A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis
|
View
|
NCT00001078 |
|
A Study on the Rate of Opportunistic AIDS-Related Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications
|
View
|
NCT02177760 |
|
Sirolimus Prophylaxis for aGVHD in TME SCID
|
View
|
NCT00000645 |
|
A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes
|
View
|
NCT00600561 |
|
Mindfulness Meditation Training in HIV
|
View
|
NCT00001357 |
|
Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients
|
View
|
NCT00008866 |
|
Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy
|
View
|
NCT00000781 |
|
A Randomized Double-Blind Four-Arm Study Comparing Combination Nucleoside Alternating Nucleoside and Triple-Drug Therapy for the Treatment of Advanced HIV Disease CD4 50mm3
|
View
|
NCT00000851 |
|
Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children
|
View
|
NCT00116415 |
|
DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy
|
View
|
NCT00116116 |
|
DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy
|
View
|
NCT00000754 |
|
A Randomized Phase II Study of Two Doses of Interferon Alfa-2a IFN Alfa-2a in Combination With Zidovudine AZT and Dideoxycytidine ddC Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cellsmm3
|
View
|
NCT00002155 |
|
A Six-Month Safety and Antiviral Study in HIV-1 Seropositive AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cellsmm3 to Evaluate MK-639 Alone Versus Zidovudine AZT and 3TC Versus the Combination of MK-639 With AZT3TC
|
View
|
NCT00005002 |
|
Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine Remune
|
View
|
NCT00001041 |
|
Active Immunization of HIV-1 Infected Pregnant Women With CD4 Lymphocyte Counts 400mm3 A Phase I Study of Safety and Immunogenicity of MN rgp120HIV-1 Vaccine NOTE Some Patients Receive Placebo
|
View
|
NCT01122186 |
|
Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men ACE
|
View
|
NCT00000921 |
|
The Effects of Prednisone on HIV Levels and the Immune System
|
View
|
NCT00000774 |
|
A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers
|
View
|
NCT02185144 |
|
PATH For Triples Study Medication and Lifestyle Adherence for HIV Patients
|
View
|
NCT00001688 |
|
A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir Nevirapine and Stavudine
|
View
|
NCT00001122 |
|
A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly
|
View
|
NCT00002323 |
|
A Multi-Center Placebo-Controlled Double-Blind Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4 Cell
|
View
|
NCT00000870 |
|
A Phase II Study of Intermittent Recombinant Human Interleukin-2 rhIL-2 by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy HAART Compared to HAART Alone
|
View
|
NCT00001109 |
|
A Blood Test to Look at Cells of the Immune System in Healthy Children
|
View
|
NCT00000962 |
|
The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients
|
View
|
NCT00001030 |
|
The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex MAC or Disseminated MAC Disease in HIV-Infected Patients
|
View
|
NCT00860769 |
|
Asha HIV Health Promotion Intervention in India
|
View
|
NCT00000747 |
|
An Open-Label Pilot Study to Evaluate the Development of Resistance to Nevirapine BI-RG-587 in HIV-Infected Patients With CD4 Cell Count 500mm3
|
View
|
NCT00000667 |
|
A Phase III Dose Escalation Study of Intradermal gp160 to Evaluate Safety Delayed Type Hypersensitivity Skin Test Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4 Cells
|
View
|
NCT00000958 |
|
A Placebo-Controlled Phase I Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3 a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1 in Combination With MTP-PEMF59 in Individuals With HIV Infection Placebo Patients Receive MF59 Emulsion Only
|
View
|
NCT00006064 |
|
The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children
|
View
|
NCT00972348 |
|
Trial Embedded in an Electronic Personal Medical Health Records
|
View
|
NCT00002007 |
|
A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia
|
View
|
NCT00000765 |
|
Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4 Lymphocyte Decline in Patients With Primary HIV Infection One Treatment Arm Receives Placebo
|
View
|
NCT00001064 |
|
A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4 T Cells 350 Cellsmm3
|
View
|
NCT00001386 |
|
Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection
|
View
|
NCT00867854 |
|
Treatment De-Intensification and Residual HIV-1 in Youth
|
View
|
NCT00006298 |
|
Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa
|
View
|
NCT00002396 |
|
The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients
|
View
|
NCT00035893 |
|
The Role of Ampligen in Strategic Therapeutic Intervention STI of HAART
|
View
|
NCT00000647 |
|
An Open Trial Combining Zidovudine Interferon-alfa and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection
|
View
|
NCT00001611 |
|
Immune Activity Against CVM Retinitis
|
View
|
NCT00002449 |
|
Safety and Effectiveness of L2-7001 Interleukin-2 in HIV-Positive Patients Receiving Anti-HIV Therapy
|
View
|
NCT00002178 |
|
A Phase IIIB Open-Label Comparative Study to Evaluate Saquinavir Soft Gel Capsule SGC Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients
|
View
|
NCT00966160 |
|
CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes
|
View
|
NCT01009762 |
|
Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection
|
View
|
NCT01014234 |
|
Rapamycin and Regulatory T Cells in Kidney Transplantation
|
View
|
NCT01042652 |
|
A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV Chinese IDUs on Methadone Maintenance
|
View
|
NCT01127464 |
|
DCVax Plus Poly ICLC in Healthy Volunteers
|
View
|
NCT02210104 |
|
Adoptive Therapy Using Antigen-Specific CD4 T-Cells
|
View
|
NCT01140139 |
|
Dermal HIV-1 Immunization During Anti-retroviral Therapy Followed by Repeated Treatment Interruptions
|
View
|
NCT02223312 |
|
Therapy for Progressive andor Refractory Hematologic Malignancies
|
View
|
NCT01195077 |
|
Could Dietary Algae Affect Immunity and Viral Counts in People With HIV
|
View
|
NCT01195467 |
|
Atripla to Raltegravir Switch Study for CNS Toxicity
|
View
|
NCT01213186 |
|
Umbilical Cord Mesenchymal Stem Cells for Immune Reconstitution in HIV-infected Patients
|
View
|
NCT01232660 |
|
Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy HAART
|
View
|
NCT01235013 |
|
Effect of Maraviroc MCV on the Immunological Recovery of HIV-1 Discordant Patients With CD4 Lymphocyte Counts Below 200 Cellsmm3
|
View
|
NCT01240811 |
|
Study of Immune Cell Changes in the Genital Tract 2 Months After Initiation of an IUD for Contraception
|
View
|
NCT01252641 |
|
Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Subjects
|
View
|
NCT01291381 |
|
Distinct Response of CD4CD25Foxp3 and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children
|
View
|
NCT01338025 |
|
Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
|
View
|
NCT01348308 |
|
Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients
|
View
|
NCT01413230 |
|
Vitamin D Supplementation in Systemic Lupus Erythematosus
|
View
|
NCT01425749 |
|
Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI
|
View
|
NCT01426243 |
|
The Yellow Fever Vaccine Immunity in HIV Infected Patients Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient
|
View
|
NCT01433601 |
|
Antiretroviral Treatment Strategies in Relation to Adherence Resistance and Virological Treatment Failure
|
View
|
NCT01433796 |
|
Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment
|
View
|
NCT01439841 |
|
The Effect of Probiotics in HIV-1 Infection
|
View
|
NCT01461876 |
|
Obesity in HIV After Antiretroviral Therapy
|
View
|
NCT01546376 |
|
Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients
|
View
|
NCT01480713 |
|
Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors
|
View
|
NCT01525459 |
|
Gene Expression Immunological Status and Metabolome in Glioma Patients
|
View
|
NCT01540240 |
|
Safety of Reduced Dose Zidovudine AZT Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients
|
View
|
NCT01541631 |
|
A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes
|
View
|
NCT01555723 |
|
Observational Study of Antiretroviral ARV Response in a Cohort of African Children Using Viral Load Monitoring
|
View
|
NCT02721719 |
|
The Role of CD4 T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis
|
View
|
NCT02742051 |
|
A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive HER2-negative Breast Cancer
|
View
|
NCT02752152 |
|
Counseling and Reminders for Regular HIV and STIs Screening
|
View
|
NCT02854618 |
|
Immune Response for Patients With Metastatic Breast Cancer Treated by Everolimus
|
View
|
NCT02811575 |
|
Type 2 Diabetes and Alteration of Immune System of Intestinal Mucosa Proof of Concept
|
View
|
NCT02831673 |
|
An Efficacy Safety and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus TenofovirEmtricitabine in Treatment naïve HIV Infected Subjects Gemini 1
|
View
|
NCT02843763 |
|
Study of Specific CD4 Tumors Th1 Responses in Renal Transplant After Occurrence of Cancer
|
View
|
NCT02846103 |
|
Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer
|
View
|
NCT04084665 |
|
Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab
|
View
|
NCT04160455 |
|
Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection Chronic Phase or Never Treated
|
View
|
NCT04202848 |
|
The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients
|
View
|
NCT05510973 |
|
Evaluation of Advanced HIV Disease Differentiated Care Model in Malawi
|
View
|
NCT05496673 |
|
Meningitis Burden Causes Screening and Prevention in Rural Northern Uganda
|
View
|
NCT00000779 |
|
A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With 500 CD4 Cellsmm3
|
View
|
NCT05537935 |
|
Low Dose Naltrexone for Pain in Patients With HIV
|
View
|
NCT00000687 |
|
Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposis Sarcoma
|
View
|
NCT00000721 |
|
An Escalating Dose Tolerance Trial of BG8962 rCD4 in Patients Who Are HIV Antibody Positive
|
View
|
NCT00002176 |
|
A Pilot Open Label Trial of HIV Therapy With d4T Stavudine ddI Didanosine Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection
|
View
|
NCT00001023 |
|
The Safety and Effectiveness of Rifabutin Combined With Clarithromycin or Azithromycin in HIV-Infected Patients
|
View
|
NCT00002336 |
|
The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex MAC Infection in HIV-Infected Patients
|
View
|
NCT00002320 |
|
A Comparison of Lamivudine and Zidovudine Used Alone and Together in HIV-Infected Patients Who Have Not Used Zidovudine in the Past
|
View
|
NCT00029913 |
|
A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials
|
View
|
NCT00035581 |
|
Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART
|
View
|
NCT00050921 |
|
Administration of Growth Hormone to Increase CD4 Count in Patients Taking Anti-HIV Drugs
|
View
|
NCT00054860 |
|
Safety of and Immune System Response to an HIV Vaccine EP HIV-1090 in HIV Uninfected Adults
|
View
|
NCT00071084 |
|
Clinical Trial of HuMax-CD4 a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin
|
View
|
NCT00131560 |
|
Safety and Efficacy of T Cell Genetic Immunotherapy for HIV
|
View
|
NCT00168259 |
|
Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals
|
View
|
NCT00180700 |
|
The Influence of Psychological Interventions Upon Disease Progression in HIV-infected Patients Receiving no Medication
|
View
|
NCT00299338 |
|
A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients
|
View
|
NCT00295698 |
|
Interaction Between HIV and Lymphatic Filariasis
|
View
|
NCT00312546 |
|
Study of Valproic Acid to Treat HIV Infected Adults
|
View
|
NCT00316589 |
|
Safety and Immunogenicity of IMVAMUNE MVA-BN Smallpox Vaccine in HIV Infected Patients
|
View
|
NCT00339430 |
|
HLA and KIR Associations With Infectious Viral Agents in an HIV Cohort of Women WIHS
|
View
|
NCT00336778 |
|
Phase 1 Pilot Study of an ART Bridging Regimen in Highly Experienced Patients Unable to Achieve Viral Suppression
|
View
|
NCT00006171 |
|
Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma
|
View
|
NCT00001067 |
|
The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs
|
View
|
NCT00000861 |
|
The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients
|
View
|
NCT00000857 |
|
A Study to Evaluate the Effects of Interleukin-12 rhIL-12 in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cellsmm3 or 300-500 Cellsmm3
|
View
|
NCT00002387 |
|
The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz
|
View
|
NCT00000712 |
|
A Multicenter Double Blind Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4 Counts Less Than 200 Cellsmm3
|
View
|
NCT00001089 |
|
A Study of HIV and Cytomegalovirus CMV in HIV-Infected Patients
|
View
|
NCT00000875 |
|
Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte CTL Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection
|
View
|
NCT00001049 |
|
A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV
|
View
|
NCT00000662 |
|
A Treatment IND for Retrovir Brand Zidovudine AZT Therapy of Pediatric Patients With HIV Disease
|
View
|
NCT00000818 |
|
Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine AZT Treatment in HIV-1-Infected Patients With CD4 Cells Between 100 and 500 Cellsmm3
|
View
|
NCT00002080 |
|
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex MAC Bacteremia in HIV Positive Patients With CD4 Counts or 200 Treatment IND Study
|
View
|
NCT00001474 |
|
Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients
|
View
|
NCT00001024 |
|
The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS
|
View
|
NCT00000750 |
|
A Phase III Study to Evaluate the Safety Tolerance and Efficacy of Early Treatment With Zidovudine AZT in Asymptomatic Infants With HIV Infection
|
View
|
NCT00002184 |
|
A Phase II Stratified Randomized Double-Blind Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil ADF at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors PI and Nucleoside Reverse Transcriptase Inhibitors RTI for the Treatment of HIV-Infected Patient
|
View
|
NCT00006152 |
|
A Study to See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment
|
View
|
NCT00000659 |
|
A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex ARC
|
View
|
NCT00000874 |
|
A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing GART Compared With Antiretroviral Management Without Plasma GART
|
View
|
NCT00002004 |
|
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 rCD4 in Patients With AIDS and AIDS-Related Complex
|
View
|
NCT00001106 |
|
A Study of Zidovudine in HIV-Infected Pregnant Women and Their Children
|
View
|
NCT00000900 |
|
The Effects of Illnesses on HIV Levels in the Body
|
View
|
NCT00004735 |
|
The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV
|
View
|
NCT00001022 |
|
A Comparison of Zidovudine AZT Used Alone or in Combination With Didanosine ddI or Dideoxycytidine ddC in HIV-Infected Patients
|
View
|
NCT00001063 |
|
The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks
|
View
|
NCT00005020 |
|
Observing Patients With Early HIV Infection
|
View
|
NCT00000777 |
|
Active Immunization of HIV-1 Infected Pregnant Women With CD4 Lymphocyte Counts 400mm3 A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 NOTE Some Patients Receive Placebo
|
View
|
NCT00000976 |
|
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G rCD4-IgG Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex
|
View
|
NCT00000649 |
|
An Open-Label Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics Safety and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection CD4 Cell Count 400mm3
|
View
|
NCT00000852 |
|
A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection
|
View
|
NCT00002443 |
|
The Safety and Effectiveness of MK-639 and Zidovudine Used Alone and Together in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
|
View
|
NCT00026676 |
|
Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine
|
View
|
NCT00028327 |
|
Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care
|
View
|
NCT00038818 |
|
CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation
|
View
|
NCT00031109 |
|
The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys
|
View
|
NCT00039689 |
|
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Primary and Chronic HIV-Infected Patients
|
View
|
NCT00034086 |
|
Study of Anti-HIV Therapy Intensification
|
View
|
NCT00051519 |
|
Screening HIV-Infected Patients for Vaccine Studies
|
View
|
NCT00091884 |
|
Efficacy of Elevated CD4 Counts on CMV Retinitis
|
View
|
NCT00110812 |
|
Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People
|
View
|
NCT00116636 |
|
Study of the 48-Week Virologic and Immunologic Response to LopinavirRitonavir Kaletra in HIV Positive Adult Patients
|
View
|
NCT00114699 |
|
Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy
|
View
|
NCT00113126 |
|
Staccato A Trial of CD4 Guided Treatment Interruption Compared to Continuous Treatment for HIV Infection
|
View
|
NCT00127881 |
|
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
|
View
|
NCT00144352 |
|
In-Vivo Response of P Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults
|
View
|
NCT00189904 |
|
Safety Tolerability and Immune Response of IMVAMUNE MVA-BNSmallpox Vaccine in HIV Infected Patients
|
View
|
NCT00196586 |
|
Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIVHCV Coinfected Patients
|
View
|
NCT00234091 |
|
When to Start Anti-HIV Drugs in Children Infected With HIV The PREDICT Study
|
View
|
NCT00244179 |
|
New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis
|
View
|
NCT00251537 |
|
A Pilot Study of LTB4 in HIV-1 Infected Adults
|
View
|
NCT00289952 |
|
Valproic Acid and Its Effects on HIV Latent Reservoirs
|
View
|
NCT00299728 |
|
NY-ESO-1 Protein With Montanide and CpG 7909 as Cancer Vaccine in Several Tumors
|
View
|
NCT00302822 |
|
Intensification With Enfuvirtide in Naive HIV-infected Patients ANRS130
|
View
|
NCT00308620 |
|
Investigating the Anti-Human Immunodeficiency Virus HIV Anti-inflammatory Effect of Chloroquine
|
View
|
NCT00310245 |
|
BASTA Study on STI in HIV Infected Patients
|
View
|
NCT00341393 |
|
Validation of System for Monitoring the Effectiveness of Antiretroviral Therapy in HIV-Infected Patients in Africa
|
View
|
NCT00350272 |
|
ElvucitabineEfavirenzTenofovir Versus LamivudineEfavirenzTenofovir in Human Immunodeficiency Virus HIV-1 Infected Treatment-naive Participants
|
View
|
NCT00372177 |
|
The Use of Anti-CD4 Monoclonal Antibody mAb-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis
|
View
|
NCT00376012 |
|
Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis
|
View
|
NCT00398996 |
|
A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy ART Initiation in HIVTuberculosis TB Co-infected Patients
|
View
|
NCT00393120 |
|
SafetyEffectiveness of Oral Chemokine Coreceptor 5 CCR5 Antagonist INCB009471 in R5-tropic HIV Infected Patients
|
View
|
NCT00411983 |
|
A Long-term Follow-up of the HIV-NAT Cohort
|
View
|
NCT00434070 |
|
Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring
|
View
|
NCT00445419 |
|
Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides
|
View
|
NCT00466258 |
|
LINFOTARGAM Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus HIV
|
View
|
NCT00472433 |
|
The Efficacy and Safety of Alemtuzumab in Auotoimmune Cytopenias
|
View
|
NCT00517803 |
|
Micronutrient Supplemented Probiotic Yogurt for HIVAIDS and Other Immunodeficiencies
|
View
|
NCT00558480 |
|
Vitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Latent Tuberculosis
|
View
|
NCT00562510 |
|
Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery
|
View
|
NCT00622232 |
|
A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial
|
View
|
NCT00646984 |
|
Strategies of InterruptionReinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy
|
View
|
NCT00643968 |
|
Tenofovir DF Efavirenz TDFEFV Versus Tenofovir DF Efavirenz Lamivudine TDFEFV3TC Maintenance Regimen in Virologically Controlled Patients COOL Trial
|
View
|
NCT00683579 |
|
Neurocognitive Assessment in Youth Initiating HAART
|
View
|
NCT00708110 |
|
Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults
|
View
|
NCT00704119 |
|
Study Evaluating the Pharmacokinetic Profile of RhuDex in a Tablet Formulation
|
View
|
NCT00746473 |
|
Assessment of Cytokine Values in Serum and by RT-PCR in HIV-1 Individuals With and Without HAART
|
View
|
NCT00765154 |
|
NNRTIPI Toxicity Switch to Darunavir Study
|
View
|
NCT00775606 |
|
Immune Reconstitution of LopinavirRitonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
|
View
|
NCT00781287 |
|
Raltegravir IsentressMK-0518 and HIV-1 Infected CD4 Cells During AcuteEarly HIV-1
|
View
|
NCT00797381 |
|
Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia
|
View
|
NCT00807625 |
|
Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia
|
View
|
NCT00817713 |
|
Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa
|
View
|
NCT00819390 |
|
Chloroquine for Reducing Immune Activation in HIV- Infected Individuals
|
View
|
NCT00820118 |
|
Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults
|
View
|
NCT00855062 |
|
Minocycline for HIV Cognitive Impairment in Uganda
|
View
|
NCT00854230 |
|
Pharmacotherapy for HIV Infected Patients With Alcohol Problems
|
View
|
NCT00856154 |
|
Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection
|
View
|
NCT00869544 |
|
Pneumocystis in Pathogenesis of HIV-associated Emphysema
|
View
|
NCT00884793 |
|
Pilot Study on the Effect of Adding Raltegravir - a Second Drug on HIV Levels in the Gut
|
View
|
NCT00884858 |
|
Maraviroc in Immunological Non-Responder INR HIV-1-infected Subjects
|
View
|
NCT00906542 |
|
Predictors of Early Chest Infection in Acute Ischemic Stroke
|
View
|
NCT00908544 |
|
New Era Study Treatment With Multi Drug Class MDC HAART in HIV Infected Patients
|
View
|
NCT02334943 |
|
Immune Activation in HIV-1 Infected Patients Under AntiRetroviral Treatment
|
View
|
NCT02369887 |
|
Evaluation of a Facility-based Test Treat and Prevent HIV Program Among Men Who Have Sex With Men and Transgender Women in Thailand
|
View
|
NCT02372708 |
|
Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy
|
View
|
NCT02390908 |
|
Improving HIV and Alcohol-Related Outcomes Among HIV Persons in Clinic Settings
|
View
|
NCT02411084 |
|
Study of BEGEDINA vs Conventional Treatment for Treating Steroid-Resistant Acute GvHD
|
View
|
NCT02490930 |
|
A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
|
View
|
NCT02544048 |
|
Markers of T Cell Suppression Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
|
View
|
NCT02559791 |
|
Anti-Interleukin-5 IL5 Monoclonal Antibody MAb in Prednisone-dependent Eosinophilic Asthma
|
View
|
NCT02604693 |
|
Exposure in Epigenetic Regulation of Immune Response in Chronic Beryllium Disease CBD
|
View
|
NCT02665559 |
|
Study of the Prevalence and Associated Factors With Hypogonadism in HIV Men
|
View
|
NCT02739048 |
|
Changes of Immunologic Function in Patients of Prostate Cancer Induced After Cryoablation
|
View
|
NCT02756949 |
|
Smart Linkage-to-HIV Care Via a Smartphone App
|
View
|
NCT02764853 |
|
Striving Towards EmPowerment and Medication Adherence STEP-AD
|
View
|
NCT02761746 |
|
Motivational Enhancement System for Adherence MESA for Youth Starting ART
|
View
|
NCT02804724 |
|
Factors Associated With Late HIV Diagnosis in Grampian an Epidemiological Study
|
View
|
NCT02838433 |
|
Study of Anti-telomerase T CD4 Immunity in Melanoma
|
View
|
NCT02842333 |
|
Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase Inhibitor
|
View
|
NCT02858414 |
|
Exploratory Study of Cellular Reservoirs in Blood From HIV Infected Patients
|
View
|
NCT02924038 |
|
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma LGG
|
View
|
NCT02934022 |
|
Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients
|
View
|
NCT02961829 |
|
Multi Interventional Study Exploring HIV-1 Residual Replication a Step Towards HIV-1 Eradication and Sterilizing Cure
|
View
|
NCT02964169 |
|
Family Planning and HIV in Postpartum Women in Mbarara
|
View
|
NCT03009032 |
|
Synbiotics in Advanced HIV Infection
|
View
|
NCT03083756 |
|
Validation of a Risk Score Opportunistic Infections Development in Kidney Transplant Patients
|
View
|
NCT03119025 |
|
Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection
|
View
|
NCT03129308 |
|
Prevalence of Cutaneous Autoimmune Phenomena in HIV Infected Patients
|
View
|
NCT03132311 |
|
Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals
|
View
|
NCT03147859 |
|
Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection
|
View
|
NCT03198559 |
|
Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ART
|
View
|
NCT03215004 |
|
Developing a Functional Cure for HIV Disease Clinical Specimen Collection From HIV Positive Individuals
|
View
|
NCT03244371 |
|
Analysis of the Impact of HCV Treatment by Last Generation Direct Antiviral Agents DAA on Antiviral Immunity and HIV DNA Reservoir in Coinfected HIV-HCV Patients
|
View
|
NCT03262441 |
|
MMF for HIV Reservoir Reduction
|
View
|
NCT03338972 |
|
Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma
|
View
|
NCT03425071 |
|
Monitoring Concentration and Pharmacodynamic Effects of Tacrolimus in Peripheral Blood Lymphocytes of Kidney Transplant Recipients
|
View
|
NCT03568812 |
|
The Role of Probiotics in HIV Patients With Immunological Non-Responder
|
View
|
NCT03587493 |
|
T-lymphocytes CD8HLA-DR and Acute Rejection After Lung Transplantation
|
View
|
NCT03638167 |
|
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
|
View
|
NCT03664440 |
|
Efficacy of Rilpivirine-based Regimens as Switch Therapy From Nevirapine-based Regimens in HIV-infected Patients
|
View
|
NCT03673345 |
|
Development of Childhood Anti-Influenza Immunity
|
View
|
NCT03691376 |
|
Genetically Engineered Cells NY-ESO-1 TCR Engineered T Cells and HSCs After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian Fallopian Tube or Primary Peritoneal Cancer
|
View
|
NCT03730545 |
|
Effect of Enteral Immunonutrition on Immune Inflammatory Markers and Nutritional Status in Patients Undergoing Gastrectomy for Gastric Cancer
|
View
|
NCT03747484 |
|
Gene-Modified Immune Cells FH-MCVA2TCR in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
|
View
|
NCT03803605 |
|
Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons
|
View
|
NCT03838497 |
|
Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Among HIV-infected Adults
|
View
|
NCT03844763 |
|
Targeting the Tumor Microenvironment in RM SCCHN
|
View
|
NCT03873649 |
|
Immune Response in Hypersensitivity Pneumonitis
|
View
|
NCT03945981 |
|
Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus HIV-1 Infected Adults
|
View
|
NCT04054089 |
|
Evaluating Inflammatory and Immunological Changes of HIV-positive Patients Switching to DTG Dual Regimen Compared to Those Switching to a Triple Drugs Regimen BFTAF
|
View
|
NCT04051970 |
|
Reducing Antiretroviral Treatments
|
View
|
NCT04067869 |
|
Cytomegalovirus Infection in Patients With HIV-1 Infection
|
View
|
NCT04117984 |
|
Swaziland HIV Incidence Measurement Survey 2
|
View
|
NCT04165200 |
|
Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIV
|
View
|